<?xml version="1.0" encoding="US-ASCII" standalone="yes" ?>
<!-- DFIN Xcelerate Instance Document - https://www.dfinsolutions.com/ -->
<!-- Version:  6.23.6 -->
<!-- Round: 5789b8e9-2545-4106-a24b-34b6e96ec0e5 -->
<!-- Creation date: 2021-01-11T20:08:42Z -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:ipoc="http://www.cloverhealth.com/20200930" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <xbrll:schemaRef xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="ipoc-20200930.xsd" xlink:type="simple" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE1111026-20S-4-0006_STD_0_20191031_0_2244216x2383821" decimals="INF" id="id_10882567_D6D0BFEE-75A1-4658-9C5D-53D08A8DCB82_2001_0" unitRef="iso4217_USD">25000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE1111026-20S-4-0006_STD_0_20200229_0_2238328x2249158_2244216x2383821" decimals="INF" id="id_10882567_02CFC972-6F71-4F02-8568-F18DE932CE34_1001_0" unitRef="iso4217_USD">300000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DueToRelatedPartiesCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20200229_0_2238328x2249158_2244216x2383821" decimals="0" id="id_10882567_02CFC972-6F71-4F02-8568-F18DE932CE34_1001_1" unitRef="iso4217_USD">300000</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE1111026-20S-4-0006_STD_0_20200424_0" decimals="2" id="id_10882567_9B056652-75D7-41BB-83E0-F97A95BA9813_1002_2" unitRef="iso4217_USD_per_shares">10.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20191017_0" decimals="0" id="id_10882567_98E3FC4E-1788-45AC-9AF4-D1A3A6142EA4_1005_800001" unitRef="iso4217_USD">0</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20191017_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_98E3FC4E-1788-45AC-9AF4-D1A3A6142EA4_1001_400002" unitRef="shares">0</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20191017_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_98E3FC4E-1788-45AC-9AF4-D1A3A6142EA4_1001_500001" unitRef="iso4217_USD">0</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20191017_0_2244216x2236750" decimals="0" id="id_10882567_98E3FC4E-1788-45AC-9AF4-D1A3A6142EA4_1003_600001" unitRef="iso4217_USD">0</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20191017_0_2244216x2249289" decimals="0" id="id_10882567_98E3FC4E-1788-45AC-9AF4-D1A3A6142EA4_1004_700001" unitRef="iso4217_USD">0</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20200331_0" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_3007_1000008" unitRef="iso4217_USD">7369</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20200331_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_3003_600009" unitRef="shares">20700000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20200331_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_3003_700008" unitRef="iso4217_USD">2070</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20200331_0_2244216x2236750" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_3005_800008" unitRef="iso4217_USD">22930</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20200331_0_2244216x2249289" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_3006_900008" unitRef="iso4217_USD">-17631</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20200630_0" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_5007_1000018" unitRef="iso4217_USD">5000002</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20200630_0_2235940x2255133_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_5001_400019" unitRef="shares">3286724</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20200630_0_2235940x2255133_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_5001_500018" unitRef="iso4217_USD">329</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20200630_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_5003_600019" unitRef="shares">20700000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20200630_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_5003_700018" unitRef="iso4217_USD">2070</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20200630_0_2244216x2236750" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_5005_800018" unitRef="iso4217_USD">5071799</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20200630_0_2244216x2249289" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_5006_900018" unitRef="iso4217_USD">-74196</us-gaap:StockholdersEquity>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="2" id="id_10882567_E3EAD4A8-D8AE-4519-A511-6C3F65D46395_1001_4" unitRef="iso4217_USD_per_shares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:OtherDeferredCostsNet contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_9164BD18-CA64-4304-AEDC-46D43F264452_1001_2" unitRef="iso4217_USD">776346</us-gaap:OtherDeferredCostsNet>
  <us-gaap:Liabilities contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_15" unitRef="iso4217_USD">30787280</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_40" unitRef="iso4217_USD">828688734</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_16" unitRef="iso4217_USD" xsi:nil="true"/>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_38" unitRef="iso4217_USD">-2367200</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_13" unitRef="iso4217_USD">1807280</us-gaap:LiabilitiesCurrent>
  <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" id="id_10882567_3378462F-CB99-4B1D-8A92-215F3BEB6A39_1001_1">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
  <us-gaap:SharesIssuedPricePerShare contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="INF" id="id_10882567_E3EAD4A8-D8AE-4519-A511-6C3F65D46395_1001_3" unitRef="iso4217_USD_per_shares">10.00</us-gaap:SharesIssuedPricePerShare>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_10" unitRef="iso4217_USD">1807280</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_2" unitRef="iso4217_USD">126745</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:PreferredStockValue contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_20" unitRef="iso4217_USD">0</us-gaap:PreferredStockValue>
  <us-gaap:AdditionalPaidInCapital contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_37" unitRef="iso4217_USD">7364781</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AssetsCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_4" unitRef="iso4217_USD">592127</us-gaap:AssetsCurrent>
  <us-gaap:Assets contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_7" unitRef="iso4217_USD">828688734</us-gaap:Assets>
  <us-gaap:CashFDICInsuredAmount contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_1F01A4E5-73EC-423E-83DE-A800D711DA08_1001_0" unitRef="iso4217_USD">250000</us-gaap:CashFDICInsuredAmount>
  <us-gaap:PrepaidExpenseCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_3" unitRef="iso4217_USD">465382</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:SharePrice contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="2" id="id_10882567_41D11FBE-BD0E-443F-ACCA-BF9A3151437F_1001_0" unitRef="iso4217_USD_per_shares">9.20</us-gaap:SharePrice>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_39" unitRef="iso4217_USD">5000003</us-gaap:StockholdersEquity>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="4" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_21" unitRef="iso4217_USD_per_shares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="INF" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_22" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="INF" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_23" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="INF" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_24" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_18" unitRef="shares">79280895</us-gaap:TemporaryEquitySharesOutstanding>
  <ipoc:AccruedOfferingCostsCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_11" unitRef="iso4217_USD">0</ipoc:AccruedOfferingCostsCurrent>
  <ipoc:DeferredOfferingCost contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_5" unitRef="iso4217_USD">0</ipoc:DeferredOfferingCost>
  <ipoc:AdvanceFromRelatedParty contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_12" unitRef="iso4217_USD">0</ipoc:AdvanceFromRelatedParty>
  <ipoc:CashAndMarketableSecuritiesHeldIntrustAccount contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_6" unitRef="iso4217_USD">828096607</ipoc:CashAndMarketableSecuritiesHeldIntrustAccount>
  <ipoc:DeferredUnderwritingFeePayableNonCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1_14" unitRef="iso4217_USD">28980000</ipoc:DeferredUnderwritingFeePayableNonCurrent>
  <ipoc:NetTangibleAssetsToBeMaintainedToProccedBusinessCombination contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_F655C3F7-5FCC-4C03-A73C-248C96E809B3_1001_0" unitRef="iso4217_USD">5000001</ipoc:NetTangibleAssetsToBeMaintainedToProccedBusinessCombination>
  <ipoc:PercentageOfStockSoldInInitialPublicOffering contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="2" id="id_10882567_E3CD8591-973C-4FCA-85A7-011C2D71DBB4_1001_0" unitRef="pure">1.00</ipoc:PercentageOfStockSoldInInitialPublicOffering>
  <ipoc:ProceedsFromRefundOfUnderwritingDiscount contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_E8140D80-7349-4B3E-B8CD-D09405BF0766_1001_1" unitRef="iso4217_USD">28980000</ipoc:ProceedsFromRefundOfUnderwritingDiscount>
  <ipoc:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsReferencePrice contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="2" id="id_10882567_3283C6E5-0C77-4DD0-AE8D-FC61736026B2_1001_0" unitRef="iso4217_USD_per_shares">18.00</ipoc:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsReferencePrice>
  <ipoc:ClassOfWarrantOrRightExercisableForCash contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="INF" id="id_10882567_A48BCE3A-511B-4DCE-92C9-96793ACFAA0C_1001_0" unitRef="shares">0</ipoc:ClassOfWarrantOrRightExercisableForCash>
  <ipoc:PercentageOfGrossProceedsOnTotalEquityProceeds contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="2" id="id_10882567_41D11FBE-BD0E-443F-ACCA-BF9A3151437F_1001_1" unitRef="pure">0.60</ipoc:PercentageOfGrossProceedsOnTotalEquityProceeds>
  <ipoc:ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValue contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="2" id="id_10882567_41D11FBE-BD0E-443F-ACCA-BF9A3151437F_1001_2" unitRef="pure">1.15</ipoc:ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValue>
  <ipoc:ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValue contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="2" id="id_10882567_41D11FBE-BD0E-443F-ACCA-BF9A3151437F_1001_4" unitRef="pure">1.80</ipoc:ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValue>
  <ipoc:CommonSharesOutstandingPercentage contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="2" id="id_10882567_FC314311-FD93-4B9B-8A9C-4C74558B792C_1001_0" unitRef="pure">0.20</ipoc:CommonSharesOutstandingPercentage>
  <ipoc:AccruedLiabilitiesCurrentRelatedParties contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_82983694-C9DE-4276-84E1-D77BF1BFE747_1002_2" unitRef="iso4217_USD">50000</ipoc:AccruedLiabilitiesCurrentRelatedParties>
  <ipoc:AmountOnDepositInTrustAccountRepresentedInterestIncome contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0" decimals="0" id="id_10882567_068C120B-AA6C-442C-92BF-165E35C4E442_1001_3" unitRef="iso4217_USD">97000</ipoc:AmountOnDepositInTrustAccountRepresentedInterestIncome>
  <us-gaap:CommonStockValue contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255133" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1001_26" unitRef="iso4217_USD">352</us-gaap:CommonStockValue>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255133" decimals="4" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1001_27" unitRef="iso4217_USD_per_shares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255133" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1001_28" unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255133" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1001_29" unitRef="shares">3519105</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255133" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1001_30" unitRef="shares">3519105</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255133" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1001_17" unitRef="iso4217_USD">792901451</us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255133" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1001_31" unitRef="shares">79280895</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255133_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_7001_400024" unitRef="shares">3519105</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255133_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_7001_500023" unitRef="iso4217_USD">352</us-gaap:StockholdersEquity>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255133_2244216x2383821" decimals="2" id="id_10882567_8030D6A8-20FA-420F-A04A-0CA9F3415853_1001_0" unitRef="iso4217_USD_per_shares">12.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:CommonStockValue contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255134" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_2001_32" unitRef="iso4217_USD">2070</us-gaap:CommonStockValue>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255134" decimals="4" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_2001_33" unitRef="iso4217_USD_per_shares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255134" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_2001_34" unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255134" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_2001_35" unitRef="shares">20700000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255134" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_2001_36" unitRef="shares">20700000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_7003_600024" unitRef="shares">20700000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_7003_700023" unitRef="iso4217_USD">2070</us-gaap:StockholdersEquity>
  <us-gaap:SharePrice contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2238403x2464594" decimals="2" id="id_10882567_EE71269F-2DA3-43C8-B201-7E716CE68D81_2001_3" unitRef="iso4217_USD_per_shares">18.00</us-gaap:SharePrice>
  <ipoc:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2238403x2464594" decimals="2" id="id_10882567_EE71269F-2DA3-43C8-B201-7E716CE68D81_2001_0" unitRef="iso4217_USD_per_shares">0.01</ipoc:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
  <us-gaap:SharePrice contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2238403x2464598" decimals="2" id="id_10882567_ED807FB4-B4A1-4A90-989C-31772B148493_2001_3" unitRef="iso4217_USD_per_shares">18.00</us-gaap:SharePrice>
  <ipoc:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2238403x2464598" decimals="2" id="id_10882567_ED807FB4-B4A1-4A90-989C-31772B148493_2001_0" unitRef="iso4217_USD_per_shares">0.10</ipoc:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
  <ipoc:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsReferencePrice contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2238403x2464598" decimals="2" id="id_10882567_3860CA04-20B9-4C84-A9B6-A508E219FFAD_1001_0" unitRef="iso4217_USD_per_shares">10.00</ipoc:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsReferencePrice>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2244216x2236750" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_7005_800023" unitRef="iso4217_USD">7364781</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2244216x2249289" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_7006_900023" unitRef="iso4217_USD">-2367200</us-gaap:StockholdersEquity>
  <us-gaap:SharePrice contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2244216x2383821" decimals="2" id="id_10882567_11384210-068B-4FB5-9F5A-ABE558CDEAF2_1001_0" unitRef="iso4217_USD_per_shares">10.00</us-gaap:SharePrice>
  <ipoc:CashAndMarketableSecuritiesHeldIntrustAccount contextRef="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2250195x2235117" decimals="0" id="id_10882567_2F7DF552-6D37-4E0D-9060-DD788AB50056_1001_1" unitRef="iso4217_USD">828096607</ipoc:CashAndMarketableSecuritiesHeldIntrustAccount>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE1111026-20S-4-0006_STD_0_20201005_0_2235940x2255133_2237543x2237544" decimals="INF" id="id_10882567_3FA78192-DC6F-4521-AB66-47DA4D25EB5E_2001_1" unitRef="iso4217_USD_per_shares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE1111026-20S-4-0006_STD_0_20201005_0_2235940x2255134_2237543x2237544_2252081x2366122" decimals="INF" id="id_10882567_7AA85624-2414-40DB-935D-227EC284DA9F_3001_1" unitRef="iso4217_USD_per_shares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20201005_0_2235940x2255134_2237543x2237544_2252081x2366122" decimals="INF" id="id_10882567_7AA85624-2414-40DB-935D-227EC284DA9F_3001_4" unitRef="shares">350000000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE1111026-20S-4-0006_STD_0_20201019_0_2237543x2237544_2238328x2381242" decimals="INF" id="id_10882567_338BF7EE-E63A-4339-879B-8184804299F7_1001_0" unitRef="iso4217_USD">2500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCredit contextRef="eol_PE1111026-20S-4-0006_STD_0_20201019_0_2237543x2237544_2238328x2381242" decimals="0" id="id_10882567_338BF7EE-E63A-4339-879B-8184804299F7_1001_1" unitRef="iso4217_USD">806208</us-gaap:LineOfCredit>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="2" id="id_10882567_F66011C2-DED6-4D27-A328-074D12F0AF64_2001_1" unitRef="iso4217_USD_per_shares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:Liabilities contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_2_15" unitRef="iso4217_USD">117977</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_32" unitRef="iso4217_USD">100346</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_11" unitRef="iso4217_USD" xsi:nil="true"/>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_30" unitRef="iso4217_USD">-17631</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_10" unitRef="iso4217_USD">117977</us-gaap:LiabilitiesCurrent>
  <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" id="id_10882567_6B772E06-EDE1-474B-824F-DACE8A42F94D_1001_2">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_2_10" unitRef="iso4217_USD">0</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_9" unitRef="iso4217_USD">0</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_2" unitRef="iso4217_USD">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:DueToRelatedPartiesCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_C242D9E7-C4EA-4F5A-AE2B-AABF27B7E633_1001_0" unitRef="iso4217_USD">10000</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:PreferredStockValue contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_14" unitRef="iso4217_USD">0</us-gaap:PreferredStockValue>
  <us-gaap:AdditionalPaidInCapital contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_29" unitRef="iso4217_USD">0</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AssetsCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_2_4" unitRef="iso4217_USD">0</us-gaap:AssetsCurrent>
  <us-gaap:Assets contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_4" unitRef="iso4217_USD">100346</us-gaap:Assets>
  <us-gaap:CashFDICInsuredAmount contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_C154AF7F-43C4-406B-82E5-2DC811E1497C_1001_0" unitRef="iso4217_USD">250000</us-gaap:CashFDICInsuredAmount>
  <us-gaap:PrepaidExpenseCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_2_3" unitRef="iso4217_USD">0</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:SharePrice contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="2" id="id_10882567_22CBD0B8-A031-47D2-AB05-845AAD15330A_1001_0" unitRef="iso4217_USD_per_shares">9.20</us-gaap:SharePrice>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_31" unitRef="iso4217_USD">-17631</us-gaap:StockholdersEquity>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="4" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_15" unitRef="iso4217_USD_per_shares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="INF" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_16" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="INF" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_17" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="INF" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_18" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
  <ipoc:AccruedOfferingCostsCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_7" unitRef="iso4217_USD">100346</ipoc:AccruedOfferingCostsCurrent>
  <ipoc:DeferredOfferingCost contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_3" unitRef="iso4217_USD">100346</ipoc:DeferredOfferingCost>
  <ipoc:DebtDueToRelatedParty contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_648919C5-A5C0-4D46-ADF1-2FD90F98FB44_1001_1" unitRef="iso4217_USD">17631</ipoc:DebtDueToRelatedParty>
  <ipoc:WorkingCapitalDeficit contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_473CD450-60DD-40EE-8FD6-92522F8A6E08_1001_1" unitRef="iso4217_USD">117977</ipoc:WorkingCapitalDeficit>
  <ipoc:AdvanceFromRelatedParty contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1_8" unitRef="iso4217_USD">17631</ipoc:AdvanceFromRelatedParty>
  <ipoc:CashAndMarketableSecuritiesHeldIntrustAccount contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_2_6" unitRef="iso4217_USD">0</ipoc:CashAndMarketableSecuritiesHeldIntrustAccount>
  <ipoc:DeferredUnderwritingFeePayableNonCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_2_14" unitRef="iso4217_USD">0</ipoc:DeferredUnderwritingFeePayableNonCurrent>
  <ipoc:NetTangibleAssetsToBeMaintainedToProccedBusinessCombination contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_5368D2AA-DD2B-4542-B1AD-A2A188F5B385_1001_0" unitRef="iso4217_USD">5000001</ipoc:NetTangibleAssetsToBeMaintainedToProccedBusinessCombination>
  <ipoc:PercentageOfStockSoldInInitialPublicOffering contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="2" id="id_10882567_ABF4EB82-837A-475C-A206-31654668D560_1001_0" unitRef="pure">1.00</ipoc:PercentageOfStockSoldInInitialPublicOffering>
  <ipoc:ProceedsFromRefundOfUnderwritingDiscount contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="0" id="id_10882567_ACEF1C61-E8FF-42F6-AC2B-510E2EE59509_1001_3" unitRef="iso4217_USD">28980000</ipoc:ProceedsFromRefundOfUnderwritingDiscount>
  <ipoc:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsReferencePrice contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="2" id="id_10882567_22CBD0B8-A031-47D2-AB05-845AAD15330A_1001_1" unitRef="iso4217_USD_per_shares">18.00</ipoc:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsReferencePrice>
  <ipoc:PercentageOfGrossProceedsOnTotalEquityProceeds contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="2" id="id_10882567_22CBD0B8-A031-47D2-AB05-845AAD15330A_1001_2" unitRef="pure">0.60</ipoc:PercentageOfGrossProceedsOnTotalEquityProceeds>
  <ipoc:ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValue contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="2" id="id_10882567_22CBD0B8-A031-47D2-AB05-845AAD15330A_1001_3" unitRef="pure">1.15</ipoc:ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValue>
  <ipoc:ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValue contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="2" id="id_10882567_22CBD0B8-A031-47D2-AB05-845AAD15330A_1001_4" unitRef="pure">1.80</ipoc:ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValue>
  <ipoc:CommonSharesOutstandingPercentage contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0" decimals="2" id="id_10882567_E804457C-7D53-4E32-8AD6-10DE2F9B3188_1001_0" unitRef="pure">0.20</ipoc:CommonSharesOutstandingPercentage>
  <us-gaap:CommonStockValue contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255133" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1001_19" unitRef="iso4217_USD">0</us-gaap:CommonStockValue>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255133" decimals="4" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1001_20" unitRef="iso4217_USD_per_shares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255133" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1001_21" unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255133" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1001_22" unitRef="shares">0</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255133" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1001_23" unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255133" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_1001_12" unitRef="iso4217_USD">0</us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255133" decimals="0" id="id_10882567_B974DD43-0E2A-4709-8430-516FD23C4342_1002_31" unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:CommonStockValue contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255134" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_2001_24" unitRef="iso4217_USD">0</us-gaap:CommonStockValue>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255134" decimals="4" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_2001_25" unitRef="iso4217_USD_per_shares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255134" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_2001_26" unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255134" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_2001_27" unitRef="shares">1</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255134" decimals="0" id="id_10882567_8E4089DD-ED2B-43F4-8B13-44F694BA2E53_2001_28" unitRef="shares">1</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_1003_600002" unitRef="shares">1</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_1003_700001" unitRef="iso4217_USD">0</us-gaap:StockholdersEquity>
  <us-gaap:SharePrice contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2238403x2464594" decimals="2" id="id_10882567_00EED9C2-119A-41FA-B82E-BFA64F97CACD_2001_3" unitRef="iso4217_USD_per_shares">18.00</us-gaap:SharePrice>
  <ipoc:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2238403x2464594" decimals="2" id="id_10882567_00EED9C2-119A-41FA-B82E-BFA64F97CACD_2001_0" unitRef="iso4217_USD_per_shares">0.01</ipoc:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
  <us-gaap:SharePrice contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2238403x2464598" decimals="2" id="id_10882567_23A436F9-B84F-4DF4-B22B-5EA8311DF45F_2001_2" unitRef="iso4217_USD_per_shares">18.00</us-gaap:SharePrice>
  <ipoc:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2238403x2464598" decimals="2" id="id_10882567_23A436F9-B84F-4DF4-B22B-5EA8311DF45F_2001_3" unitRef="iso4217_USD_per_shares">0.10</ipoc:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
  <ipoc:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsReferencePrice contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2238403x2464598" decimals="2" id="id_10882567_23A436F9-B84F-4DF4-B22B-5EA8311DF45F_2001_0" unitRef="iso4217_USD_per_shares">10.00</ipoc:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsReferencePrice>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2244216x2236750" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_1005_800001" unitRef="iso4217_USD">0</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2244216x2249289" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_1006_900001" unitRef="iso4217_USD">-17631</us-gaap:StockholdersEquity>
  <us-gaap:SharePrice contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2244216x2383821" decimals="2" id="id_10882567_A610E5F2-0F8A-461D-ACF7-138476F26E28_1001_0" unitRef="iso4217_USD_per_shares">10.00</us-gaap:SharePrice>
  <ipoc:SharesIssuedMinimumPricePerShareAfterAdjustments contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2249317x2412147" decimals="2" id="id_10882567_80E008CD-C1A8-44D0-95F7-FD70574C058B_2001_1" unitRef="iso4217_USD_per_shares">12.00</ipoc:SharesIssuedMinimumPricePerShareAfterAdjustments>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2251395x2251396" decimals="2" id="id_10882567_76198381-3CF8-40B1-A599-5FCE601A72F2_3001_4" unitRef="iso4217_USD_per_shares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE1111026-20S-4-0006_STD_0_20200121_0_2237543x2237544_2238328x2249158_2244216x2383821" decimals="INF" id="id_10882567_EB026F0A-B2E4-4585-BF34-53AC4B4A8745_1001_0" unitRef="iso4217_USD">300000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DueToRelatedPartiesCurrent contextRef="eol_PE1111026-20S-4-0006_STD_0_20200121_0_2237543x2237544_2238328x2249158_2244216x2383821" decimals="2" id="id_10882567_EB026F0A-B2E4-4585-BF34-53AC4B4A8745_1001_1" unitRef="iso4217_USD">3000.00</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE1111026-20S-4-0006_STD_0_20200121_0_2237543x2237544_2244216x2383821" decimals="INF" id="id_10882567_483E23E2-5AED-463B-8B6F-A54BAE91F3AD_2001_1" unitRef="iso4217_USD">25000</us-gaap:DebtInstrumentFaceAmount>
  <ipoc:SponsorMonthlyFeePayable contextRef="eol_PE1111026-20S-4-0006_STD_1_20200421_0" decimals="0" id="id_10882567_82983694-C9DE-4276-84E1-D77BF1BFE747_1_0" unitRef="iso4217_USD">10000</ipoc:SponsorMonthlyFeePayable>
  <ipoc:RelatedPartyTransactionSharesOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor contextRef="eol_PE1111026-20S-4-0006_STD_1_20200421_0_2237543x2237544_2244216x2383821" decimals="0" id="id_10882567_483E23E2-5AED-463B-8B6F-A54BAE91F3AD_1002_0" unitRef="shares">20700000</ipoc:RelatedPartyTransactionSharesOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor>
  <ipoc:RelatedPartyTransactionPercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor contextRef="eol_PE1111026-20S-4-0006_STD_1_20200421_0_2237543x2237544_2244216x2383821_2251395x2251400" decimals="2" id="id_10882567_B121E727-809A-40EE-83FC-F2CF26D1A047_1001_1" unitRef="pure">0.20</ipoc:RelatedPartyTransactionPercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor>
  <ipoc:RelatedPartyTransactionSharesOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor contextRef="eol_PE1111026-20S-4-0006_STD_1_20200421_0_2237543x2237544_2244216x2383821_2251395x2251400" decimals="0" id="id_10882567_B121E727-809A-40EE-83FC-F2CF26D1A047_1001_0" unitRef="shares">2700000</ipoc:RelatedPartyTransactionSharesOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor>
  <ipoc:RelatedPartyTransactionSharesOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor contextRef="eol_PE1111026-20S-4-0006_STD_1_20200421_0_2244216x2383821" decimals="0" id="id_10882567_D6D0BFEE-75A1-4658-9C5D-53D08A8DCB82_1002_2" unitRef="shares">20700000</ipoc:RelatedPartyTransactionSharesOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="eol_PE1111026-20S-4-0006_STD_1_20200424_0" decimals="0" id="id_10882567_9B056652-75D7-41BB-83E0-F97A95BA9813_2_1" unitRef="iso4217_USD">828000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE1111026-20S-4-0006_STD_1_20200424_0" decimals="INF" id="id_10882567_9B056652-75D7-41BB-83E0-F97A95BA9813_2_0" unitRef="shares">82800000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE1111026-20S-4-0006_STD_1_20200424_0_2251395x2251400" decimals="INF" id="id_10882567_9B056652-75D7-41BB-83E0-F97A95BA9813_1_0" unitRef="shares">10800000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <ipoc:CommonStockVotingRightsPerShare contextRef="eol_PE1111026-20S-4-0006_STD_1_20201005_0_2235940x2255133_2237543x2237544" decimals="0" id="id_10882567_3FA78192-DC6F-4521-AB66-47DA4D25EB5E_1001_2" unitRef="Vote">1</ipoc:CommonStockVotingRightsPerShare>
  <ipoc:ConversionOfCommonStockDescription contextRef="eol_PE1111026-20S-4-0006_STD_1_20201005_0_2235940x2255133_2237543x2237544" id="id_10882567_3FA78192-DC6F-4521-AB66-47DA4D25EB5E_1001_0">(i) each of the then issued and outstanding Class A ordinary shares, par value $0.0001 per share, of the Company (the &#x201C;Class A Ordinary Shares&#x201D;), will convert automatically, on a one-for-one basis, into a share of Class A common stock, par value $0.0001 per share, of the Company (after its Domestication) (the &#x201C;Class A Common Stock&#x201D;, and together with the Class B Common Stock, the &#x201C;Common Stock&#x201D;), which will be entitled to one vote per share, (ii) each of the then issued and outstanding Class B ordinary shares, par value $0.0001 per share, of the Company, will convert automatically, on a one-for-one basis, into a share of Class A Common Stock, (iii) each then issued and outstanding warrant of the Company will convert automatically into a warrant to acquire one share of Class A Common Stock (&#x201C;Domesticated Warrant&#x201D;), pursuant to the Warrant Agreement, dated April 21, 2020, between the Company and Continental Stock Transfer &amp; Trust Company, as warrant agent, and (iv) each then issued and outstanding unit of the Company (the &#x201C;Cayman Units&#x201D;) will convert automatically into a unit of the Company (after the Domestication) (the &#x201C;Domesticated Units&#x201D;), with each Domesticated Unit representing one share of Class A Common Stock and one-third of one Domesticated Warrant.</ipoc:ConversionOfCommonStockDescription>
  <us-gaap:PaymentsToAcquireBusinessesGross contextRef="eol_PE1111026-20S-4-0006_STD_1_20201005_0_2235940x2255134_2237543x2237544_2246129x2246008_2252081x2366122" decimals="INF" id="id_10882567_7AA85624-2414-40DB-935D-227EC284DA9F_1001_3" unitRef="iso4217_USD">500000000</us-gaap:PaymentsToAcquireBusinessesGross>
  <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="eol_PE1111026-20S-4-0006_STD_1_20201005_0_2235940x2255134_2237543x2237544_2252081x2366122" decimals="0" id="id_10882567_7AA85624-2414-40DB-935D-227EC284DA9F_2001_5" unitRef="iso4217_USD">3500000000</us-gaap:BusinessCombinationConsiderationTransferred1>
  <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableDescription contextRef="eol_PE1111026-20S-4-0006_STD_1_20201005_0_2235940x2255134_2237543x2237544_2252081x2366122" id="id_10882567_7AA85624-2414-40DB-935D-227EC284DA9F_2001_0">As a result of the Mergers, among other things, (i) all outstanding shares of common stock of Clover immediately prior to the effective time of the First Merger will be cancelled in exchange for the right to receive, at the election of the holders thereof (except with respect to the shares held by entities controlled by Vivek Garipalli and certain other holders who will receive only shares of Class B common stock, par value $0.0001 per share, which will be entitled to 10 votes per share (the &#x201C;Class B Common Stock&#x201D;)), an amount in cash, shares of Class B Common Stock, or a combination thereof, as adjusted in accordance with the Merger Agreement, which in the aggregate will equal an amount in cash of up to $500,000,000 (less any redemptions by the Company&#x2019;s public shareholders) and a number of shares of Class B Common Stock equal to (A) 350,000,000 minus (B) the aggregate amount of Class B Common Stock to be paid in respect of the shares held by entities controlled by Vivek Garipalli and certain other holders, minus (C) the aggregate amount of Class B Common Stock that would be issuable upon the net exercise or conversion, as applicable, of the employee equity awards of the combined company immediately after the effective time of the First Merger, minus (D) the quotient obtained by dividing (x) the total cash consideration by (y) $10.00; (ii) all outstanding shares of Clover held by entities controlled by Vivek Garipalli and certain other holders immediately prior to the effective time of the First Merger will be cancelled in exchange for the right to receive shares of Class B Common Stock based on the Exchange Ratio (as defined in the Merger Agreement); and (iii) all shares of common stock of Clover reserved in respect of the employee equity awards of Clover outstanding as of immediately prior to the effective time of the First Merger, will be converted, based on the Exchange Ratio, into awards based on shares of Class B Common Stock, which will, in the case of all shares described in clauses (i), (ii) and (iii) hereof, in the aggregate equal an aggregate merger consideration of $3,500,000,000.</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableDescription>
  <ipoc:CommonStockVotingRightsPerShare contextRef="eol_PE1111026-20S-4-0006_STD_1_20201005_0_2235940x2255134_2237543x2237544_2252081x2366122" decimals="0" id="id_10882567_7AA85624-2414-40DB-935D-227EC284DA9F_2001_2" unitRef="Vote">10</ipoc:CommonStockVotingRightsPerShare>
  <us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod contextRef="eol_PE1111026-20S-4-0006_STD_1_20201019_0_2237543x2237544_2238328x2381242" decimals="0" id="id_10882567_FABEAA09-055A-4EDA-AF1A-9CE45AA67153_1001_0" unitRef="iso4217_USD">2500000</us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod>
  <us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal contextRef="eol_PE1111026-20S-4-0006_STD_1_20201019_0_2237543x2237544_2238328x2381242" decimals="0" id="id_10882567_FABEAA09-055A-4EDA-AF1A-9CE45AA67153_1001_1" unitRef="iso4217_USD">806208</us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal>
  <ipoc:RelatedPartyTransactionNumberOfSharesHeld contextRef="eol_PE1111026-20S-4-0006_STD_1_20200121_0_2237543x2237544_2244216x2383821" decimals="0" id="id_10882567_483E23E2-5AED-463B-8B6F-A54BAE91F3AD_1001_2" unitRef="shares">17250000</ipoc:RelatedPartyTransactionNumberOfSharesHeld>
  <ipoc:RelatedPartyTransactionSharesOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor contextRef="eol_PE1111026-20S-4-0006_STD_1_20200121_0_2237543x2237544_2244216x2383821" decimals="0" id="id_10882567_483E23E2-5AED-463B-8B6F-A54BAE91F3AD_1001_0" unitRef="shares">1</ipoc:RelatedPartyTransactionSharesOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_10" unitRef="iso4217_USD">-828000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_19" unitRef="iso4217_USD">829231023</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:IncreaseDecreaseInOperatingCapital contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_068C120B-AA6C-442C-92BF-165E35C4E442_1_2" unitRef="iso4217_USD">1215153</us-gaap:IncreaseDecreaseInOperatingCapital>
  <dei:DocumentType contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_7FD3B038-436F-42C4-A87C-2E9A8488ED18_1_0">S-1</dei:DocumentType>
  <dei:AmendmentFlag contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_7FD3B038-436F-42C4-A87C-2E9A8488ED18_1_1">false</dei:AmendmentFlag>
  <dei:EntityRegistrantName contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_584B178F-53B7-44EA-88C6-5BC6138ED4CE_1_1">CLOVER HEALTH INVESTMENTS, CORP. /DE</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_584B178F-53B7-44EA-88C6-5BC6138ED4CE_1_2">0001801170</dei:EntityCentralIndexKey>
  <dei:EntityFilerCategory contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_584B178F-53B7-44EA-88C6-5BC6138ED4CE_1_3">Non-accelerated Filer</dei:EntityFilerCategory>
  <dei:EntitySmallBusiness contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_584B178F-53B7-44EA-88C6-5BC6138ED4CE_1_4">true</dei:EntitySmallBusiness>
  <dei:EntityEmergingGrowthCompany contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_584B178F-53B7-44EA-88C6-5BC6138ED4CE_1_5">true</dei:EntityEmergingGrowthCompany>
  <dei:EntityExTransitionPeriod contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_584B178F-53B7-44EA-88C6-5BC6138ED4CE_1_6">false</dei:EntityExTransitionPeriod>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_2_3" unitRef="iso4217_USD">96607</us-gaap:InvestmentIncomeInterest>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_2_4" unitRef="iso4217_USD">-2349569</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="2" id="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_2_6" unitRef="iso4217_USD_per_shares">-0.12</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_2_1" unitRef="iso4217_USD">-2446176</us-gaap:OperatingIncomeLoss>
  <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_5" unitRef="iso4217_USD">465382</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_7" unitRef="iso4217_USD">-1104278</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_A02166F9-F815-4316-9B80-EDEB88312E28_1_2" unitRef="iso4217_USD">2898000</us-gaap:BusinessCombinationConsiderationTransferred1>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_12" unitRef="iso4217_USD">25000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_14" unitRef="iso4217_USD">16400000</us-gaap:ProceedsFromIssuanceOfWarrants>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_20" unitRef="iso4217_USD">126745</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
  <us-gaap:CostOfTrustAssetsSoldToPayExpenses contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_11384210-068B-4FB5-9F5A-ABE558CDEAF2_1_1" unitRef="iso4217_USD">100000</us-gaap:CostOfTrustAssetsSoldToPayExpenses>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_2_5" unitRef="shares">20157288</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_20A96946-14CA-436E-BE60-7D567315BAE1_1_1" unitRef="shares">38533333</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:ProfitLoss contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_1" unitRef="iso4217_USD">-2349569</us-gaap:ProfitLoss>
  <us-gaap:TemporaryEquityNetIncome contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_944ACFA1-B2C4-4215-90F1-7349EBA04FBE_2_0" unitRef="iso4217_USD">-92501</us-gaap:TemporaryEquityNetIncome>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_82983694-C9DE-4276-84E1-D77BF1BFE747_3_1" unitRef="iso4217_USD">50000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="INF" id="id_10882567_E3EAD4A8-D8AE-4519-A511-6C3F65D46395_1_1" unitRef="shares">82800000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_6" unitRef="iso4217_USD">1807280</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:ProceedsFromNotesPayable contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_16" unitRef="iso4217_USD">300000</us-gaap:ProceedsFromNotesPayable>
  <us-gaap:RepaymentsOfNotesPayable contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_17" unitRef="iso4217_USD">300000</us-gaap:RepaymentsOfNotesPayable>
  <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_15" unitRef="iso4217_USD">17631</us-gaap:RepaymentsOfRelatedPartyDebt>
  <us-gaap:PaymentOfFinancingAndStockIssuanceCosts contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_18" unitRef="iso4217_USD">776346</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
  <ipoc:DeferredUnderwritingFeePayable contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_9164BD18-CA64-4304-AEDC-46D43F264452_1_4" unitRef="iso4217_USD">28980000</ipoc:DeferredUnderwritingFeePayable>
  <ipoc:ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_13" unitRef="iso4217_USD">813600000</ipoc:ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid>
  <ipoc:DeferredUnderwritingFees contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="2" id="id_10882567_E8140D80-7349-4B3E-B8CD-D09405BF0766_1_0" unitRef="iso4217_USD">0.35</ipoc:DeferredUnderwritingFees>
  <ipoc:InitialPublicOfferingCosts contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_9164BD18-CA64-4304-AEDC-46D43F264452_1_0" unitRef="iso4217_USD">44156346</ipoc:InitialPublicOfferingCosts>
  <ipoc:FormationAndOperatingCosts contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_2_0" unitRef="iso4217_USD">2446176</ipoc:FormationAndOperatingCosts>
  <ipoc:PaymentsToAcquireInvestmentsToBeHeldInTrustAccount contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_9" unitRef="iso4217_USD">828000000</ipoc:PaymentsToAcquireInvestmentsToBeHeldInTrustAccount>
  <ipoc:InitialClassificationOfOrdinarySharesSubjectToPossibleRedemption contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_24" unitRef="iso4217_USD">795251020</ipoc:InitialClassificationOfOrdinarySharesSubjectToPossibleRedemption>
  <ipoc:ChangeInOrdinarySharesPossibleRedemptionValue contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_25" unitRef="iso4217_USD">-2349569</ipoc:ChangeInOrdinarySharesPossibleRedemptionValue>
  <ipoc:UnderwritingFeeDeferred contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_F3BE6BAF-ACBF-43F7-A8EF-DD12110E6B88_1_26" unitRef="iso4217_USD">28980000</ipoc:UnderwritingFeeDeferred>
  <ipoc:AdjustedNetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_32E9D1AE-D63E-4A63-97F9-D035A1E8590F_2_3" unitRef="iso4217_USD">-2442070</ipoc:AdjustedNetIncomeLoss>
  <ipoc:AdditionalPurchaseOfUnderwritingShares contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_E3EAD4A8-D8AE-4519-A511-6C3F65D46395_1_2" unitRef="shares">10800000</ipoc:AdditionalPurchaseOfUnderwritingShares>
  <ipoc:CashWithDrawnFromTrustAccount contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_9164BD18-CA64-4304-AEDC-46D43F264452_1_3" unitRef="iso4217_USD">126745</ipoc:CashWithDrawnFromTrustAccount>
  <ipoc:RefundsFromUnderwritingDiscount contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_A02166F9-F815-4316-9B80-EDEB88312E28_1_1" unitRef="iso4217_USD">1440000</ipoc:RefundsFromUnderwritingDiscount>
  <ipoc:UnderwritingDiscountPercentage contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="2" id="id_10882567_A02166F9-F815-4316-9B80-EDEB88312E28_1_0" unitRef="pure">0.10</ipoc:UnderwritingDiscountPercentage>
  <ipoc:WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_3378462F-CB99-4B1D-8A92-215F3BEB6A39_1_0">P12M</ipoc:WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering>
  <ipoc:ThresholdPeriodForFillingRegistrationStatementAfterBusinessCombination contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_7DECB1BA-17E1-4C3A-82B3-B0D37FD498E5_1_0">P15D</ipoc:ThresholdPeriodForFillingRegistrationStatementAfterBusinessCombination>
  <ipoc:ThresholdPeriodForFilingRegistrationStatementWithinNumberOfDaysOfBusinessCombination contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_7DECB1BA-17E1-4C3A-82B3-B0D37FD498E5_1_1">P60D</ipoc:ThresholdPeriodForFilingRegistrationStatementWithinNumberOfDaysOfBusinessCombination>
  <ipoc:UnderwritingFees contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" decimals="0" id="id_10882567_9164BD18-CA64-4304-AEDC-46D43F264452_1_1" unitRef="iso4217_USD">14400000</ipoc:UnderwritingFees>
  <ipoc:CommonStockVotingRightsPerShare contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2235940x2255133" decimals="INF" id="id_10882567_7BE95942-4682-4C88-BEDA-215284D27B5F_1001_2" unitRef="Vote">1</ipoc:CommonStockVotingRightsPerShare>
  <ipoc:CommonStockVotingRightsPerShare contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2235940x2255134" decimals="INF" id="id_10882567_90A66560-A755-4BCA-8BC0-8675A600E8DE_1001_2" unitRef="Vote">1</ipoc:CommonStockVotingRightsPerShare>
  <ipoc:NumberOfSharesSubjectToForfeitureIfOverAllotmentOptionIsNotFullyExercisedByUnderwriters contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2235940x2255134" decimals="0" id="id_10882567_B2A7036D-EE15-4F65-942A-AD41C6783FAE_2001_1" unitRef="shares">2700000</ipoc:NumberOfSharesSubjectToForfeitureIfOverAllotmentOptionIsNotFullyExercisedByUnderwriters>
  <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2238403x2380265" decimals="0" id="id_10882567_960053C9-2A78-48AB-936A-A1A76A879214_1001_2" unitRef="iso4217_USD">16400000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
  <ipoc:ClassOfWarrantOrRightPerWarrant contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2238403x2380265" decimals="2" id="id_10882567_960053C9-2A78-48AB-936A-A1A76A879214_1001_1" unitRef="iso4217_USD_per_shares">1.50</ipoc:ClassOfWarrantOrRightPerWarrant>
  <ipoc:ClassOfWarrantOrRightNumbersIssued contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2238403x2380265" decimals="0" id="id_10882567_960053C9-2A78-48AB-936A-A1A76A879214_1001_0" unitRef="shares">10933333</ipoc:ClassOfWarrantOrRightNumbersIssued>
  <ipoc:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2238403x2464594" id="id_10882567_EE71269F-2DA3-43C8-B201-7E716CE68D81_1001_1">P30D</ipoc:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
  <ipoc:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2238403x2464594" id="id_10882567_EE71269F-2DA3-43C8-B201-7E716CE68D81_1001_2">P20D</ipoc:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
  <ipoc:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2238403x2464598" id="id_10882567_ED807FB4-B4A1-4A90-989C-31772B148493_1001_1">P30D</ipoc:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
  <ipoc:RelatedPartyTransactionPercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2244216x2383821_2251395x2251400" decimals="2" id="id_10882567_7BFF6C30-02E6-4818-B985-1407BD39CD25_1001_1" unitRef="pure">0.20</ipoc:RelatedPartyTransactionPercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor>
  <ipoc:RelatedPartyTransactionSharesOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2244216x2383821_2251395x2251400" decimals="0" id="id_10882567_7BFF6C30-02E6-4818-B985-1407BD39CD25_1001_0" unitRef="shares">2700000</ipoc:RelatedPartyTransactionSharesOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor>
  <ipoc:LoansConvertibleInToWarrants contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2246129x2246008_2252772x2380357" decimals="0" id="id_10882567_E7DE58C4-44A2-445B-9A0A-BA4C344B5C73_2001_0" unitRef="iso4217_USD">1500000</ipoc:LoansConvertibleInToWarrants>
  <ipoc:WarrantsPricePerUnit contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2252772x2380357" decimals="2" id="id_10882567_E7DE58C4-44A2-445B-9A0A-BA4C344B5C73_3001_2" unitRef="iso4217_USD_per_shares">1.50</ipoc:WarrantsPricePerUnit>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE1111026-20S-4-0006_STD_31_20191031_0" decimals="INF" id="id_10882567_D4D665A8-39A5-4F2D-A66F-D86FD26FAB87_1_0" unitRef="shares">1</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="eol_PE1111026-20S-4-0006_STD_31_20191031_0" decimals="0" id="id_10882567_D4D665A8-39A5-4F2D-A66F-D86FD26FAB87_1_1" unitRef="iso4217_USD">0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
  <ipoc:RelatedPartyTransactionNumberOfSharesHeld contextRef="eol_PE1111026-20S-4-0006_STD_31_20191031_0_2244216x2383821" decimals="0" id="id_10882567_D6D0BFEE-75A1-4658-9C5D-53D08A8DCB82_1001_1" unitRef="shares">17250000</ipoc:RelatedPartyTransactionNumberOfSharesHeld>
  <ipoc:RelatedPartyTransactionSharesOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor contextRef="eol_PE1111026-20S-4-0006_STD_31_20191031_0_2244216x2383821" decimals="0" id="id_10882567_40B7502C-C63C-4D6B-9752-2572C07D92A6_1001_0" unitRef="shares">1</ipoc:RelatedPartyTransactionSharesOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor>
  <ipoc:RelatedPartyTransactionSharesOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor contextRef="eol_PE1111026-20S-4-0006_STD_31_20191031_0_2251395x2251400" decimals="0" id="id_10882567_40B7502C-C63C-4D6B-9752-2572C07D92A6_2001_1" unitRef="shares">0</ipoc:RelatedPartyTransactionSharesOfIssuedAndOutstandingSharesAfterInitialPublicOfferingHeldBySponsor>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_E1FB392E-47A7-4586-902C-8959C1BB4E21_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Net Loss per Ordinary Share&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Net loss per ordinary share is computed by dividing net loss by the
 weighted average number of ordinary shares outstanding for the
 period. The Company applies the &lt;font style="WHITE-SPACE: nowrap"&gt;two-class&lt;/font&gt; method in calculating
 earnings per share. Ordinary shares subject to possible redemption
 at September&amp;#xA0;30, 2020, which are not currently redeemable and
 are not redeemable at fair value, have been excluded from the
 calculation of basic net loss per ordinary share since such shares,
 if redeemed, only participate in their pro rata share of the Trust
 Account earnings. The Company has not considered the effect of
 warrants sold in the Initial Public Offering and the private
 placement to purchase 38,533,333 ordinary shares in the calculation
 of diluted loss per share, since the exercise of the warrants into
 ordinary shares is contingent upon the occurrence of future events.
 As a result, diluted net loss per ordinary share is the same as
 basic net loss per ordinary share for the periods presented.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 18pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Reconciliation of Net Loss Per Ordinary Share&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company&amp;#x2019;s net loss is adjusted for the portion of income
 that is attributable to ordinary shares subject to possible
 redemption, as these shares only participate in the earnings of the
 Trust Account and not the income or losses of the Company.
 Accordingly, basic and diluted loss per ordinary share is
 calculated as follows:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="76%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;Three Months&lt;br /&gt;
 Ended&lt;br /&gt;
 September&amp;#xA0;30,&lt;br /&gt;
 2020&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;Nine Months&lt;br /&gt;
 Ended&lt;br /&gt;
 September&amp;#xA0;30,&lt;br /&gt;
 2020&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net loss&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,293,004&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,349,569&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Less: Income attributable to ordinary shares subject to possible
 redemption&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(30,986&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(92,501&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Adjusted net loss&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,323,990&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,442,070&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Weighted average shares outstanding, basic and diluted&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;23,986,724&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;20,157,288&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Basic and diluted net loss per ordinary share&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(0.10&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(0.12&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_1D6E8292-6DA7-4DB6-9291-0F9520884CBD_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;NOTE 7. SHAREHOLDERS&amp;#x2019; EQUITY&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;&lt;i&gt;Preferred Shares&lt;/i&gt;&lt;/b&gt;&amp;#xA0;&amp;#x2014;&amp;#xA0;The Company is
 authorized to issue 5,000,000 preference shares with a par value of
 $0.0001. The Company&amp;#x2019;s board of directors will be authorized
 to fix the voting rights, if any, designations, powers,
 preferences, the relative, participating, optional or other special
 rights and any qualifications, limitations and restrictions
 thereof, applicable to the shares of each series. The board of
 directors will be able to, without shareholder approval, issue
 preferred shares with voting and other rights that could adversely
 affect the voting power and other rights of the holders of the
 ordinary shares and could have anti-takeover effects. At
 September&amp;#xA0;30, 2020 and December&amp;#xA0;31, 2019, there were no
 preferred shares issued or outstanding.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;&lt;i&gt;Class&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;&amp;#xA0;A Ordinary
 Shares&lt;/i&gt;&lt;/b&gt;&amp;#xA0;&amp;#x2014; The Company is authorized
 to issue 500,000,000 Class&amp;#xA0;A ordinary shares, with a par value
 of $0.0001 per share. Holders of Class&amp;#xA0;A ordinary shares are
 entitled to one vote for each share. At September&amp;#xA0;30, 2020 and
 December&amp;#xA0;31, 2019, there were 3,519,105 and no Class&amp;#xA0;A
 ordinary shares issued or outstanding, excluding 79,280,895 and no
 Class&amp;#xA0;A ordinary shares subject to possible redemption,
 respectively.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;&lt;i&gt;Class&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;&amp;#xA0;B Ordinary
 Shares&lt;/i&gt;&lt;/b&gt;&amp;#xA0;&amp;#x2014; The Company is authorized
 to issue 50,000,000 Class&amp;#xA0;B ordinary shares, with a par value
 of $0.0001 per share. Holders of the Class&amp;#xA0;B ordinary shares
 are entitled to one vote for each share. At September&amp;#xA0;30, 2020
 and December&amp;#xA0;31, 2019, there were 20,700,000 and one
 Class&amp;#xA0;B ordinary shares issued and outstanding,
 respectively.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 Only holders of the Class&amp;#xA0;B ordinary shares will have the
 right to vote on the election of directors prior to the Business
 Combination. Holders of Class&amp;#xA0;A ordinary shares and holders of
 Class&amp;#xA0;B ordinary shares will vote together as a single class
 on all matters submitted to a vote of our shareholders except as
 otherwise required by law.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Class&amp;#xA0;B ordinary shares will automatically convert into
 Class&amp;#xA0;A ordinary shares at the time of the completion of the
 Business Combination, or earlier at the option of the holder, on
 a&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;&lt;font style="WHITE-SPACE: nowrap"&gt;one-for-one&lt;/font&gt;&lt;/font&gt;&amp;#xA0;basis,
 subject to adjustment. In the case that additional Class&amp;#xA0;A
 ordinary shares, or equity-linked securities, are issued or deemed
 issued in excess of the amounts issued in the Initial Public
 Offering and related to the closing of a Business Combination, the
 ratio at which Founder Shares will convert into Class&amp;#xA0;A
 ordinary shares will be adjusted (subject to waiver by holders of a
 majority of the Class&amp;#xA0;B ordinary shares) so that the number of
 Class&amp;#xA0;A ordinary shares issuable upon conversion of all
 Founder Shares will equal, in the aggregate, on
 an&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;as-converted&lt;/font&gt;&amp;#xA0;basis,
 20% of the sum of the ordinary shares issued and outstanding upon
 completion of the Initial Public Offering plus the number of
 Class&amp;#xA0;A ordinary shares and equity-linked securities issued or
 deemed issued in connection with a Business Combination (net of
 redemptions), excluding any Class&amp;#xA0;A ordinary shares or
 equity-linked securities issued, or to be issued, to any seller in
 a Business Combination and any Private Placement Warrants issued to
 the Sponsor.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&amp;#xA0;&amp;#x2014; Public Warrants
 may only be exercised for a whole number of shares. No fractional
 shares will be issued upon exercise of the Public Warrants. The
 Public Warrants will become exercisable on the later of
 (a)&amp;#xA0;30&amp;#xA0;days after the completion of a Business
 Combination and (b)&amp;#xA0;12 months from the closing of the Initial
 Public Offering. The Public Warrants will expire five years from
 the completion of a Business Combination or earlier upon redemption
 or liquidation.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company will not be obligated to deliver any Class&amp;#xA0;A
 ordinary shares pursuant to the exercise of a Public Warrant and
 will have no obligation to settle such Public Warrant exercise
 unless a registration statement under the Securities Act covering
 the issuance of the Class&amp;#xA0;A ordinary shares issuable upon
 exercise of the Public Warrants is then effective and a prospectus
 relating thereto is current, subject to the Company satisfying its
 obligations with respect to registration. No Public Warrant will be
 exercisable for cash or on a cashless basis, and the Company will
 not be obligated to issue any shares to holders seeking to exercise
 their Public Warrants, unless the issuance of the shares upon such
 exercise is registered or qualified under the securities laws of
 the state of the exercising holder, or an exemption from
 registration is available.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company has agreed that as soon as practicable, but in no event
 later than 15 business days, after the closing of a Business
 Combination, it will use its commercially reasonable efforts to
 file with the SEC a registration statement registering the
 issuance, under the Securities Act, of the Class&amp;#xA0;A ordinary
 shares issuable upon exercise of the Public Warrants. The Company
 will use it commercially reasonable efforts to cause the same to
 become effective within 60 business days after the closing of the
 Business Combination and to maintain the effectiveness of such
 registration statement, and a current prospectus relating thereto,
 until the expiration of the Public Warrants in accordance with the
 provisions of the warrant agreement. Notwithstanding the above, if
 the Class&amp;#xA0;A ordinary shares are, at the time of any exercise
 of a Public Warrant, not listed on a national securities exchange
 such that they satisfy the definition of a &amp;#x201C;covered
 security&amp;#x201D; under Section&amp;#xA0;18(b)(1)&amp;#xA0;of the Securities
 Act, the Company may, at its option, require holders of Public
 Warrants who exercise their Public Warrants to do so on a
 &amp;#x201C;cashless basis&amp;#x201D; in accordance with
 Section&amp;#xA0;3(a)(9)&amp;#xA0;of the Securities Act and, in the event
 the Company so elects, the Company will not be required to file or
 maintain in effect a registration statement, but will use its
 commercially reasonable efforts to qualify the shares under
 applicable blue sky laws to the extent an exemption is not
 available.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;i&gt;Redemption of warrants when the price per Class&amp;#xA0;A ordinary
 share equals or exceeds $18.00. Once the Public Warrants become
 exercisable, the Company may redeem the Public Warrants:&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="break-inside: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-TOP: 0pt" align="left"&gt;in whole and not in part;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="break-inside: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-TOP: 0pt" align="left"&gt;at a price of $0.01 per Public Warrant;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="break-inside: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-TOP: 0pt" align="left"&gt;upon not less than 30 days&amp;#x2019; prior written notice
 of redemption to each warrant holder and&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="break-inside: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-TOP: 0pt" align="left"&gt;if, and only if, the reported last sale price of the
 Class&amp;#xA0;A ordinary shares for any 20 trading days within
 a&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;30-trading&lt;/font&gt;&amp;#xA0;day
 period ending on the third trading day prior to the date on which
 the Company sends the notice of redemption to the warrant holders
 (the &amp;#x201C;Reference Value&amp;#x201D;) equals or exceeds $18.00 per
 share (as adjusted for share splits, share dividends, rights
 issuances, subdivisions, reorganizations, recapitalizations and the
 like).&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;i&gt;Redemption of warrants when the price per Class&lt;/i&gt;&lt;i&gt;&amp;#xA0;A
 ordinary share equals or exceeds $10.00.&lt;/i&gt;&amp;#xA0;Once
 the Public Warrants become exercisable, the Company may redeem the
 Public Warrants:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="break-inside: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-TOP: 0pt" align="left"&gt;in whole and not in part;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="break-inside: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-TOP: 0pt" align="left"&gt;at $0.10 per warrant upon a minimum of 30 days&amp;#x2019;
 prior written notice of redemption provided that holders will be
 able to exercise their warrants on a cashless basis prior to
 redemption and receive that number of shares based on the
 redemption date and the &amp;#x201C;fair market value&amp;#x201D; of the
 Class&amp;#xA0;A ordinary shares;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="break-inside: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-TOP: 0pt" align="left"&gt;if, and only if, the Reference Value equals or exceeds
 $10.00 per share (as adjusted for share splits, share dividends,
 rights issuances, subdivisions, reorganizations, recapitalizations
 and the like); and&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="break-inside: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-TOP: 0pt" align="left"&gt;if the Reference Value is less than $18.00 per share
 (as adjusted for share splits, share dividends, rights issuances,
 subdivisions, reorganizations, recapitalizations and the like) the
 Private Placement Warrants must also be concurrently called for
 redemption on the same terms as the outstanding Public Warrants, as
 described above.&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 If and when the Public Warrants become redeemable by the Company,
 the Company may exercise its redemption right even if it is unable
 to register or qualify the underlying securities for sale under all
 applicable state securities laws.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The exercise price and number of ordinary shares issuable upon
 exercise of the Public Warrants may be adjusted in certain
 circumstances including in the event of a share dividend,
 extraordinary dividend or recapitalization, reorganization, merger
 or consolidation. However, except as described below, the Public
 Warrants will not be adjusted for issuances of ordinary shares at a
 price below its exercise price. Additionally, in no event will the
 Company be required to net cash settle the Public Warrants. If the
 Company is unable to complete a Business Combination within the
 Combination Period and the Company liquidates the funds held in the
 Trust Account, holders of Public Warrants will not receive any of
 such funds with respect to their Public Warrants, nor will they
 receive any distribution from the Company&amp;#x2019;s assets held
 outside of the Trust Account with respect to such Public Warrants.
 Accordingly, the Public Warrants may expire worthless.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 In addition, if&amp;#xA0; (x)&amp;#xA0;the Company issues additional
 Class&amp;#xA0;A ordinary shares or equity-linked securities for
 capital raising purposes in connection with the closing of a
 Business Combination at an issue price or effective issue price of
 less than $9.20 per Class&amp;#xA0;A ordinary share (with such issue
 price or effective issue price to be determined in good faith by
 the Company&amp;#x2019;s board of directors, and in the case of any such
 issuance to the Sponsor or its affiliates, without taking into
 account any Founder Shares held by the Sponsor or such affiliates,
 as applicable, prior to such issuance) (the &amp;#x201C;Newly Issued
 Price&amp;#x201D;), (y)&amp;#xA0;the aggregate gross proceeds from such
 issuances represent more than 60% of the total equity proceeds, and
 interest thereon, available for the funding of a Business
 Combination on the date of the completion of a Business Combination
 (net of redemptions), and (z)&amp;#xA0;the volume weighted average
 trading price of the Company&amp;#x2019;s ordinary shares during the 20
 trading day period starting on the trading day prior to the day on
 which the Company consummates a Business Combination (such price,
 the &amp;#x201C;Market Value&amp;#x201D;) is below $9.20 per share, the
 exercise price of the Public Warrants will be adjusted (to the
 nearest cent) to be equal to 115% of the higher of the Market Value
 and the Newly Issued Price, and the $18.00 per share redemption
 trigger prices described above will be adjusted (to the nearest
 cent) to be equal to 180% of the higher of the Market Value and the
 Newly Issued Price.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Private Placement Warrants are identical to the Public Warrants
 underlying the Units sold in the Initial Public Offering, except
 that the Private Placement Warrants and the Class&amp;#xA0;A ordinary
 shares issuable upon the exercise of the Private Placement Warrants
 will not be transferable, assignable or salable until 30&amp;#xA0;days
 after the completion of a Business Combination, subject to certain
 limited exceptions. Additionally, the Private Placement Warrants
 will be exercisable on a cashless basis and
 be&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;non-redeemable&lt;/font&gt;&amp;#xA0;except
 as described above so long as they are held by the initial
 purchasers or their permitted transferees. If the Private Placement
 Warrants are held by someone other than the initial purchasers or
 their permitted transferees, the Private Placement Warrants will be
 redeemable by the Company and exercisable by such holders on the
 same basis as the Public Warrants.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_8B6F5EFF-B1F6-473F-ABEB-E616A66752CF_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;NOTE 6. COMMITMENTS&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;Registration Rights&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Pursuant to a registration rights agreement entered into on
 April&amp;#xA0;21, 2020, the holders of the Founder Shares, Private
 Placement Warrants and warrants that may be issued upon conversion
 of Working Capital Loans (and any Class&amp;#xA0;A ordinary shares
 issuable upon the exercise of the Private Placement Warrants or
 warrants issued upon conversion of the Working Capital Loans and
 upon conversion of the Founder Shares) will be entitled to
 registration rights requiring the Company to register such
 securities for resale (in the case of the Founder Shares, only
 after conversion to the Company&amp;#x2019;s Class&amp;#xA0;A ordinary
 shares). The holders of these securities will be entitled to make
 up to three demands, excluding short form registration demands,
 that the Company register such securities. In addition, the holders
 have certain &amp;#x201C;piggy-back&amp;#x201D; registration rights with
 respect to registration statements filed subsequent to the
 completion of a Business Combination and rights to require the
 Company to register for resale such securities pursuant to
 Rule&amp;#xA0;415 under the Securities Act. However, the registration
 rights agreement provides that the Company will not be required to
 effect or permit any registration or cause any registration
 statement to become effective until termination of the applicable
 &lt;font style="WHITE-SPACE: nowrap"&gt;lock-up&lt;/font&gt; period. The
 Company will bear the expenses incurred in connection with the
 filing of any such registration statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Underwriting Agreement&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The underwriters are entitled to a deferred fee of&amp;#xA0;$0.35 per
 Unit, or $28,980,000 in the aggregate. The deferred fee will become
 payable to the underwriters from the amounts held in the Trust
 Account solely in the event that the Company completes a Business
 Combination, subject to the terms of the underwriting
 agreement.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 18pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Financial Advisory Fee&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The underwriters agreed to reimburse the Company for an amount
 equal to 10% of the discount paid to the underwriters for financial
 advisory services provided by Connaught (UK) Limited in connection
 with the Initial Public Offering, of which $1,440,000 was paid at
 the closing of the Initial Public Offering and up to $2,898,000
 will be payable at the time of the closing of a Business
 Combination.&lt;/p&gt;


 &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_CE1C9E73-5FCC-40EE-A5A1-460FFE2D48D7_1_0">&lt;div&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="76%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;Three Months&lt;br /&gt;
 Ended&lt;br /&gt;
 September&amp;#xA0;30,&lt;br /&gt;
 2020&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;Nine Months&lt;br /&gt;
 Ended&lt;br /&gt;
 September&amp;#xA0;30,&lt;br /&gt;
 2020&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net loss&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,293,004&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,349,569&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Less: Income attributable to ordinary shares subject to possible
 redemption&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(30,986&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(92,501&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Adjusted net loss&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,323,990&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,442,070&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Weighted average shares outstanding, basic and diluted&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;23,986,724&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;20,157,288&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Basic and diluted net loss per ordinary share&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(0.10&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(0.12&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_2F4D76D7-E1C1-456D-A9B8-07B14676580F_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Recent Accounting Standards&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Management does not believe that any recently issued, but not yet
 effective, accounting standards, if currently adopted, would have a
 material effect on the accompanying condensed financial
 statements.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:UseOfEstimates contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_B43B23B9-B143-404E-B616-072AC3689087_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The preparation of the condensed financial statements in conformity
 with GAAP requires the Company&amp;#x2019;s management to make estimates
 and assumptions that affect the reported amounts of assets and
 liabilities and disclosure of contingent assets and liabilities at
 the date of the condensed financial statements and the reported
 amounts of revenues and expenses during the reporting period.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 Making estimates requires management to exercise significant
 judgment. It is at least reasonably possible that the estimate of
 the effect of a condition, situation or set of circumstances that
 existed at the date of the financial statements, which management
 considered in formulating its estimate, could change in the near
 term due to one or more future confirming events. Accordingly, the
 actual results could differ significantly from those estimates.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_7F40180B-F726-49E3-8810-9B5EB5AF5A1F_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The following table presents information about the Company&amp;#x2019;s
 assets that are measured at fair value on a recurring basis at
 September&amp;#xA0;30, 2020 and indicates the fair value hierarchy of
 the valuation inputs the Company utilized to determine such fair
 value:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="76%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-BOTTOM: #000000 1pt solid; MARGIN-TOP: 0pt; DISPLAY: table-cell"&gt;
 Description&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;Level&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;September&amp;#xA0;30,&lt;br /&gt;
 2020&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td valign="bottom"&gt;Assets:&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Cash and Marketable securities held in Trust Account&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;828,096,607&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_ED1865E5-E185-4CCE-A992-701D88765756_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company accounts for income taxes under ASC 740, &amp;#x201C;Income
 Taxes&amp;#x201D; (&amp;#x201C;ASC 740&amp;#x201D;). ASC 740 requires the
 recognition of deferred tax assets and liabilities for both the
 expected impact of differences between the financial statement and
 tax basis of assets and liabilities and for the expected future tax
 benefit to be derived from tax loss and tax credit carry forwards.
 ASC 740 additionally requires a valuation allowance to be
 established when it is more likely than not that all or a portion
 of deferred tax assets will not be realized.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 ASC 740 also clarifies the accounting for uncertainty in income
 taxes recognized in an enterprise&amp;#x2019;s financial statements and
 prescribes a recognition threshold and measurement process for
 financial statement recognition and measurement of a tax position
 taken or expected to be taken in a tax return. For those benefits
 to be recognized, a tax position must be &lt;font style="WHITE-SPACE: nowrap"&gt;more-likely-than-not&lt;/font&gt; to be sustained
 upon examination by taxing authorities. The Company recognizes
 accrued interest and penalties related to unrecognized tax benefits
 as income tax expense. There were no unrecognized tax benefits and
 no amounts accrued for interest and penalties as of
 September&amp;#xA0;30, 2020 and December&amp;#xA0;31, 2019. The Company is
 currently not aware of any issues under review that could result in
 significant payments, accruals or material deviation from its
 position. The Company is subject to income tax examinations by
 major taxing authorities since inception.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company is considered an exempted Cayman Islands Company and is
 presently not subject to income taxes or income tax filing
 requirements in the Cayman Islands or the United States. As such,
 the Company&amp;#x2019;s tax provision was zero for the period
 presented.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 On March&amp;#xA0;27, 2020, President Trump signed the Coronavirus Aid,
 Relief, and Economic Security &amp;#x201C;CARES&amp;#x201D; Act into law. The
 CARES Act includes several significant business tax provisions
 that, among other things, would eliminate the taxable income limit
 for certain net operating losses (&amp;#x201C;NOLs&amp;#x201D;) and allow
 businesses to carry back NOLs arising in 2018, 2019 and 2020 to the
 five prior years, suspend the excess business loss rules,
 accelerate refunds of previously generated corporate alternative
 minimum tax credits, generally loosen the business interest
 limitation under IRC section 163(j)&amp;#xA0;from 30&amp;#xA0;percent to
 50&amp;#xA0;percent among other technical corrections included in the
 Tax Cuts and Jobs Act tax provisions. The Company does not believe
 that the CARES Act will have a significant impact on
 Company&amp;#x2019;s financial position or statement of operations.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_CE06DD63-5B7A-48B3-9C16-992E389E3BBA_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The accompanying unaudited condensed financial statements have been
 prepared in accordance with accounting principles generally
 accepted in the United States of America (&amp;#x201C;GAAP&amp;#x201D;) for
 interim financial information and in accordance with the
 instructions to&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;Form&amp;#xA0;10-Q&lt;/font&gt;&amp;#xA0;and
 Article&amp;#xA0;8 of&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;Regulation&amp;#xA0;S-X&lt;/font&gt;&amp;#xA0;of
 the Securities and Exchange Commission (the &amp;#x201C;SEC&amp;#x201D;).
 Certain information or footnote disclosures normally included in
 financial statements prepared in accordance with GAAP have been
 condensed or omitted, pursuant to the rules&amp;#xA0;and regulations of
 the SEC for interim financial reporting. Accordingly, they do not
 include all the information and footnotes necessary for a complete
 presentation of financial position, results of operations, or cash
 flows. In the opinion of management, the accompanying unaudited
 condensed financial statements include all adjustments, consisting
 of a normal recurring nature, which are necessary for a fair
 presentation of the financial position, operating results and cash
 flows for the periods presented.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The accompanying unaudited condensed financial statements should be
 read in conjunction with the Company&amp;#x2019;s prospectus for its
 Initial Public Offering as filed with the SEC on April&amp;#xA0;23,
 2020, as well as the Company&amp;#x2019;s Current Reports
 on&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;Form&amp;#xA0;8-K,&lt;/font&gt;&amp;#xA0;as
 filed with the SEC on April&amp;#xA0;24, 2020 and April&amp;#xA0;30, 2020.
 The interim results for the three and nine months ended
 September&amp;#xA0;30, 2020 are not necessarily indicative of the
 results to be expected for the year ending December&amp;#xA0;31, 2020
 or for any future periods.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Emerging Growth Company&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company is an &amp;#x201C;emerging growth company,&amp;#x201D; as defined
 in Section&amp;#xA0;2(a)&amp;#xA0;of the Securities Act, as modified by the
 Jumpstart Our Business Startups Act of 2012 (the &amp;#x201C;JOBS
 Act&amp;#x201D;), and it may take advantage of certain exemptions from
 various reporting requirements that are applicable to other public
 companies that are not emerging growth companies including, but not
 limited to, not being required to comply with the independent
 registered public accounting firm attestation requirements of
 Section&amp;#xA0;404 of the Sarbanes-Oxley Act, reduced disclosure
 obligations regarding executive compensation in its periodic
 reports and proxy statements, and exemptions from the requirements
 of holding a nonbinding advisory vote on executive compensation and
 shareholder approval of any golden parachute payments not
 previously approved.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 Further, Section&amp;#xA0;102(b)(1)&amp;#xA0;of the JOBS Act exempts
 emerging growth companies from being required to comply with new or
 revised financial accounting standards until private companies
 (that is, those that have not had a Securities Act registration
 statement declared effective or do not have a class of securities
 registered under the Exchange Act) are required to comply with the
 new or revised financial accounting standards. The JOBS Act
 provides that a company can elect to opt out of the extended
 transition period and comply with the requirements that apply
 to&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;non-emerging&lt;/font&gt;&amp;#xA0;growth
 companies but any such election to opt out is irrevocable. The
 Company has elected not to opt out of such extended transition
 period which means that when a standard is issued or revised and it
 has different application dates for public or private companies,
 the Company, as an emerging growth company, can adopt the new or
 revised standard at the time private companies adopt the new or
 revised standard. This may make comparison of the Company&amp;#x2019;s
 financial statements with another public company which is neither
 an emerging growth company nor an emerging growth company which has
 opted out of using the extended transition period difficult or
 impossible because of the potential differences in accounting
 standards used.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The preparation of the condensed financial statements in conformity
 with GAAP requires the Company&amp;#x2019;s management to make estimates
 and assumptions that affect the reported amounts of assets and
 liabilities and disclosure of contingent assets and liabilities at
 the date of the condensed financial statements and the reported
 amounts of revenues and expenses during the reporting period.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 Making estimates requires management to exercise significant
 judgment. It is at least reasonably possible that the estimate of
 the effect of a condition, situation or set of circumstances that
 existed at the date of the financial statements, which management
 considered in formulating its estimate, could change in the near
 term due to one or more future confirming events. Accordingly, the
 actual results could differ significantly from those estimates.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company considers all short-term investments with an original
 maturity of three months or less when purchased to be cash
 equivalents. The Company did not have any cash equivalents as of
 September&amp;#xA0;30, 2020 and December&amp;#xA0;31, 2019.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Cash and Marketable Securities Held in Trust Account&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 At September&amp;#xA0;30, 2020, the assets held in the Trust Account
 were primarily invested in money market funds, which invest in U.S.
 Treasury securities.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Class&amp;#xA0;A Ordinary Shares Subject to Possible
 Redemption&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company accounts for its Class&amp;#xA0;A ordinary shares subject
 to possible redemption in accordance with the guidance in
 Accounting Standards Codification (&amp;#x201C;ASC&amp;#x201D;) Topic 480
 &amp;#x201C;Distinguishing Liabilities from Equity.&amp;#x201D; Class&amp;#xA0;A
 ordinary shares subject to mandatory redemption are classified as a
 liability instrument and are measured at fair value. Conditionally
 redeemable ordinary shares (including ordinary shares that feature
 redemption rights that are either within the control of the holder
 or subject to redemption upon the occurrence of uncertain events
 not solely within the Company&amp;#x2019;s control) are classified as
 temporary equity. At all other times, ordinary shares are
 classified as shareholders&amp;#x2019; equity. The Company&amp;#x2019;s
 Class&amp;#xA0;A ordinary shares feature certain redemption rights that
 are considered to be outside of the Company&amp;#x2019;s control and
 subject to occurrence of uncertain future events. Accordingly,
 Class&amp;#xA0;A ordinary shares subject to possible redemption are
 presented at redemption value as temporary equity, outside of the
 shareholders&amp;#x2019; equity section of the Company&amp;#x2019;s condensed
 balance sheets.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 18pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company accounts for income taxes under ASC 740, &amp;#x201C;Income
 Taxes&amp;#x201D; (&amp;#x201C;ASC 740&amp;#x201D;). ASC 740 requires the
 recognition of deferred tax assets and liabilities for both the
 expected impact of differences between the financial statement and
 tax basis of assets and liabilities and for the expected future tax
 benefit to be derived from tax loss and tax credit carry forwards.
 ASC 740 additionally requires a valuation allowance to be
 established when it is more likely than not that all or a portion
 of deferred tax assets will not be realized.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 ASC 740 also clarifies the accounting for uncertainty in income
 taxes recognized in an enterprise&amp;#x2019;s financial statements and
 prescribes a recognition threshold and measurement process for
 financial statement recognition and measurement of a tax position
 taken or expected to be taken in a tax return. For those benefits
 to be recognized, a tax position must
 be&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;more-likely-than-not&lt;/font&gt;&amp;#xA0;to
 be sustained upon examination by taxing authorities. The Company
 recognizes accrued interest and penalties related to unrecognized
 tax benefits as income tax expense. There were no unrecognized tax
 benefits and no amounts accrued for interest and penalties as of
 September&amp;#xA0;30, 2020 and December&amp;#xA0;31, 2019. The Company is
 currently not aware of any issues under review that could result in
 significant payments, accruals or material deviation from its
 position. The Company is subject to income tax examinations by
 major taxing authorities since inception.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company is considered an exempted Cayman Islands Company and is
 presently not subject to income taxes or income tax filing
 requirements in the Cayman Islands or the United States. As such,
 the Company&amp;#x2019;s tax provision was zero for the period
 presented.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 On March&amp;#xA0;27, 2020, President Trump signed the Coronavirus Aid,
 Relief, and Economic Security &amp;#x201C;CARES&amp;#x201D; Act into law. The
 CARES Act includes several significant business tax provisions
 that, among other things, would eliminate the taxable income limit
 for certain net operating losses (&amp;#x201C;NOLs&amp;#x201D;) and allow
 businesses to carry back NOLs arising in 2018, 2019 and 2020 to the
 five prior years, suspend the excess business loss rules,
 accelerate refunds of previously generated corporate alternative
 minimum tax credits, generally loosen the business interest
 limitation under IRC section 163(j)&amp;#xA0;from 30&amp;#xA0;percent to
 50&amp;#xA0;percent among other technical corrections included in the
 Tax Cuts and Jobs Act tax provisions. The Company does not believe
 that the CARES Act will have a significant impact on
 Company&amp;#x2019;s financial position or statement of operations.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Net Loss per Ordinary Share&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 Net loss per ordinary share is computed by dividing net loss by the
 weighted average number of ordinary shares outstanding for the
 period. The Company applies the&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;two-class&lt;/font&gt;&amp;#xA0;method in
 calculating earnings per share. Ordinary shares subject to possible
 redemption at September&amp;#xA0;30, 2020, which are not currently
 redeemable and are not redeemable at fair value, have been excluded
 from the calculation of basic net loss per ordinary share since
 such shares, if redeemed, only participate in their pro rata share
 of the Trust Account earnings. The Company has not considered the
 effect of warrants sold in the Initial Public Offering and the
 private placement to purchase 38,533,333 ordinary shares in the
 calculation of diluted loss per share, since the exercise of the
 warrants into ordinary shares is contingent upon the occurrence of
 future events. As a result, diluted net loss per ordinary share is
 the same as basic net loss per ordinary share for the periods
 presented.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 18pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Reconciliation of Net Loss Per Ordinary Share&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company&amp;#x2019;s net loss is adjusted for the portion of income
 that is attributable to ordinary shares subject to possible
 redemption, as these shares only participate in the earnings of the
 Trust Account and not the income or losses of the Company.
 Accordingly, basic and diluted loss per ordinary share is
 calculated as follows:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="76%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; break-inside: avoid"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;Three Months&lt;br /&gt;
 Ended&lt;br /&gt;
 September&amp;#xA0;30,&lt;br /&gt;
 2020&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;Nine Months&lt;br /&gt;
 Ended&lt;br /&gt;
 September&amp;#xA0;30,&lt;br /&gt;
 2020&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; break-inside: avoid" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net loss&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,293,004&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,349,569&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; break-inside: avoid"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Less: Income attributable to ordinary shares subject to possible
 redemption&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(30,986&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(92,501&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; break-inside: avoid" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Adjusted net loss&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,323,990&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,442,070&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; break-inside: avoid"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Weighted average shares outstanding, basic and diluted&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;23,986,724&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;20,157,288&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; break-inside: avoid" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Basic and diluted net loss per ordinary share&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(0.10&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(0.12&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 Financial instruments that potentially subject the Company to
 concentrations of credit risk consist of a cash account in a
 financial institution which, at times may exceed the Federal
 Depository Insurance Coverage of $250,000. The Company has not
 experienced losses on this account and management believes the
 Company is not exposed to significant risks on such account.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The fair value of the Company&amp;#x2019;s assets and liabilities, which
 qualify as financial instruments under ASC Topic 820, &amp;#x201C;Fair
 Value Measurement,&amp;#x201D; approximates the carrying amounts
 represented in the accompanying condensed balance sheets, primarily
 due to their short-term nature.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Recent Accounting Standards&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 Management does not believe that any recently issued, but not yet
 effective, accounting standards, if currently adopted, would have a
 material effect on the accompanying condensed financial
 statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Risks and Uncertainties&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 Management continues to evaluate the impact of
 the&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;COVID-19&lt;/font&gt;&amp;#xA0;pandemic
 and has concluded that while it is reasonably possible that the
 virus could have a negative effect on the Company&amp;#x2019;s financial
 position, results of its operations and/or search for a target
 company, the specific impact is not readily determinable as of the
 date of these financial statements. The financial statements do not
 include any adjustments that might result from the outcome of this
 uncertainty.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:SubsequentEventsTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_BEFDECC9-3784-49F1-BC11-752BD3A7B691_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;NOTE 9.&amp;#xA0;SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company evaluated subsequent events and transactions that
 occurred after the balance sheet date up to the date that the
 condensed financial statements were issued. Based upon this review,
 other than as described below, the Company did not identify any
 subsequent events that would have required adjustment or disclosure
 in the condensed financial statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 On October&amp;#xA0;19, 2020, the Company issued an unsecured
 promissory note to the Sponsor (the &amp;#x201C;Promissory Note&amp;#x201D;),
 pursuant to which the Company may borrow up to an aggregate
 principal amount of $2,500,000. The Promissory Note is &lt;font style="WHITE-SPACE: nowrap"&gt;non-interest&lt;/font&gt; bearing and payable on
 the earlier of (i)&amp;#xA0;April&amp;#xA0;24, 2022 and (ii)&amp;#xA0;the
 completion of the Business Combination. On October&amp;#xA0;19, 2020,
 the Company borrowed $806,208 under the Promissory Note.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Merger Agreement&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 On October&amp;#xA0;5, 2020, the Company entered into an Agreement and
 Plan of Merger (the &amp;#x201C;Merger Agreement&amp;#x201D;) with Merger Sub
 and Clover.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 Pursuant to the transactions contemplated by the terms of the
 Merger Agreement (the &amp;#x201C;Closing&amp;#x201D;), and subject to the
 satisfaction or waiver of certain conditions set forth therein,
 (i)&amp;#xA0;Merger Sub will merge with and into Clover, with Clover
 surviving the merger and as a wholly owned subsidiary of the
 Company (the &amp;#x201C;First Merger&amp;#x201D;) and (ii)&amp;#xA0;Clover will
 merge with and into the Company, with the Company surviving the
 merger (together with the First Merger, the &amp;#x201C;Mergers&amp;#x201D;)
 (the transactions contemplated by the Merger Agreement and the
 related ancillary agreements, the &amp;#x201C; Clover Business
 Combination&amp;#x201D;).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 As a result of the Mergers, among other things, (i) all outstanding
 shares of common stock of Clover immediately prior to the effective
 time of the First Merger will be cancelled in exchange for the
 right to receive, at the election of the holders thereof (except
 with respect to the shares held by entities controlled by Vivek
 Garipalli and certain other holders who will receive only shares of
 Class&amp;#xA0;B common stock, par value $0.0001 per share, which will
 be entitled to 10 votes per share (the &amp;#x201C;Class B Common
 Stock&amp;#x201D;)), an amount in cash, shares of Class&amp;#xA0;B Common
 Stock, or a combination thereof, as adjusted in accordance with the
 Merger Agreement, which in the aggregate will equal an amount in
 cash of up to $500,000,000 (less any redemptions by the
 Company&amp;#x2019;s public shareholders) and a number of shares of
 Class&amp;#xA0;B Common Stock equal to (A)&amp;#xA0;350,000,000 minus
 (B)&amp;#xA0;the aggregate amount of Class&amp;#xA0;B Common Stock to be
 paid in respect of the shares held by entities controlled by Vivek
 Garipalli and certain other holders, minus (C)&amp;#xA0;the aggregate
 amount of Class&amp;#xA0;B Common Stock that would be issuable upon the
 net exercise or conversion, as applicable, of the employee equity
 awards of the combined company immediately after the effective time
 of the First Merger, minus (D)&amp;#xA0;the quotient obtained by
 dividing (x)&amp;#xA0;the total cash consideration by (y)&amp;#xA0;$10.00;
 (ii)&amp;#xA0;all outstanding shares of Clover held by entities
 controlled by Vivek Garipalli and certain other holders immediately
 prior to the effective time of the First Merger will be cancelled
 in exchange for the right to receive shares of Class B Common Stock
 based on the Exchange Ratio (as defined in the Merger Agreement);
 and (iii)&amp;#xA0;all shares of common stock of Clover reserved in
 respect of the employee equity awards of Clover outstanding as of
 immediately prior to the effective time of the First Merger, will
 be converted, based on the Exchange Ratio, into awards based on
 shares of Class&amp;#xA0;B Common Stock, which will, in the case of all
 shares described in clauses (i), (ii) and (iii) hereof, in the
 aggregate equal an aggregate merger consideration of
 $3,500,000,000.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 Prior to the Closing, subject to the approval of the
 Company&amp;#x2019;s shareholders, and in accordance with the General
 Corporation Law of the State of Delaware (the &amp;#x201C;DGCL&amp;#x201D;),
 Cayman Islands Companies Law (2020 Revision) (the
 &amp;#x201C;CICL&amp;#x201D;) and the Company&amp;#x2019;s Amended and Restated
 Memorandum and Articles of Association (as may be amended from time
 to time, the &amp;#x201C;Cayman Constitutional Documents&amp;#x201D;), the
 Company will effect a deregistration under the CICL and a
 domestication under Section&amp;#xA0;388 of the DGCL (by means of
 filing a certificate of domestication with the Secretary of State
 of Delaware), pursuant to which the Company&amp;#x2019;s jurisdiction of
 incorporation will be changed from the Cayman Islands to the State
 of Delaware (the &amp;#x201C;Domestication&amp;#x201D;).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 In connection with the Domestication, (i)&amp;#xA0;each of the then
 issued and outstanding Class&amp;#xA0;A ordinary shares, par value
 $0.0001 per share, of the Company (the &amp;#x201C;Class&amp;#xA0;A Ordinary
 Shares&amp;#x201D;), will convert automatically, on a &lt;font style="WHITE-SPACE: nowrap"&gt;&lt;font style="WHITE-SPACE: nowrap"&gt;one-for-one&lt;/font&gt;&lt;/font&gt; basis, into a share
 of Class&amp;#xA0;A common stock, par value $0.0001 per share, of the
 Company (after its Domestication) (the &amp;#x201C;Class&amp;#xA0;A Common
 Stock&amp;#x201D;, and together with the Class&amp;#xA0;B Common Stock, the
 &amp;#x201C;Common Stock&amp;#x201D;), which will be entitled to one vote per
 share, (ii)&amp;#xA0;each of the then issued and outstanding
 Class&amp;#xA0;B ordinary shares, par value $0.0001 per share, of the
 Company, will convert automatically, on a &lt;font style="WHITE-SPACE: nowrap"&gt;&lt;font style="WHITE-SPACE: nowrap"&gt;one-for-one&lt;/font&gt;&lt;/font&gt; basis, into a share
 of Class&amp;#xA0;A Common Stock, (iii)&amp;#xA0;each then issued and
 outstanding warrant of the Company will convert automatically into
 a warrant to acquire one share of Class&amp;#xA0;A Common Stock
 (&amp;#x201C;Domesticated Warrant&amp;#x201D;), pursuant to the Warrant
 Agreement, dated April&amp;#xA0;21, 2020, between the Company and
 Continental Stock Transfer&amp;#xA0;&amp;amp; Trust Company, as warrant
 agent, and (iv)&amp;#xA0;each then issued and outstanding unit of the
 Company that has not been previously separated into the underlying
 Class A Ordinary Share and underlying warrant of the Company upon
 the request of the holder thereof, will be cancelled and will
 entitle the holder thereof to one share of Class&amp;#xA0;A Common
 Stock and &lt;font style="WHITE-SPACE: nowrap"&gt;one-third&lt;/font&gt; of one
 Domesticated Warrant.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Clover Business Combination will be consummated subject to
 certain conditions as further described in the Merger
 Agreement.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 18pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Legal Proceedings&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 On October 29, 2020, Paul Chaplin, a purported stockholder of the
 Company, filed a lawsuit in the Supreme Court of the State of New
 York, County of New York, captioned Paul Chaplin v. Social Capital
 Hedosophia Holdings Corp. III, et al., case number 655802/2020,
 against the Company and the members of its board of directors (the
 &amp;#x201C;Chaplin Complaint&amp;#x201D;). The Chaplin Complaint asserts a
 breach of fiduciary duty claim against the individual defendants
 and an aiding and abetting claim against the Company in connection
 with the proposed business combination. The Chaplin Complaint
 alleges, among other things, that (i) defendants engaged in a
 flawed and unfair sales process and agreed to inadequate
 consideration in connection with the proposed Business Combination,
 and (ii) that our Registration Statement on Form S-4 filed with the
 SEC on October 20, 2020 in connection with the proposed Business
 Combination is materially misleading and incomplete. The Chaplin
 Complaint seeks, among other things, to enjoin the proposed
 Business Combination, rescind the transaction or award rescissory
 damages to the extent it is consummated, and an award of
 attorneys&amp;#x2019; fees and expenses.&lt;/p&gt;


 &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_EC14C43F-42B5-4921-8D2A-D418EAED69C0_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The accompanying unaudited condensed financial statements have been
 prepared in accordance with accounting principles generally
 accepted in the United States of America (&amp;#x201C;GAAP&amp;#x201D;) for
 interim financial information and in accordance with the
 instructions to&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;Form&amp;#xA0;10-Q&lt;/font&gt;&amp;#xA0;and
 Article&amp;#xA0;8 of&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;Regulation&amp;#xA0;S-X&lt;/font&gt;&amp;#xA0;of
 the Securities and Exchange Commission (the &amp;#x201C;SEC&amp;#x201D;).
 Certain information or footnote disclosures normally included in
 financial statements prepared in accordance with GAAP have been
 condensed or omitted, pursuant to the rules&amp;#xA0;and regulations of
 the SEC for interim financial reporting. Accordingly, they do not
 include all the information and footnotes necessary for a complete
 presentation of financial position, results of operations, or cash
 flows. In the opinion of management, the accompanying unaudited
 condensed financial statements include all adjustments, consisting
 of a normal recurring nature, which are necessary for a fair
 presentation of the financial position, operating results and cash
 flows for the periods presented.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The accompanying unaudited condensed financial statements should be
 read in conjunction with the Company&amp;#x2019;s prospectus for its
 Initial Public Offering as filed with the SEC on April&amp;#xA0;23,
 2020, as well as the Company&amp;#x2019;s Current Reports
 on&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;Form&amp;#xA0;8-K,&lt;/font&gt;&amp;#xA0;as
 filed with the SEC on April&amp;#xA0;24, 2020 and April&amp;#xA0;30, 2020.
 The interim results for the three and nine months ended
 September&amp;#xA0;30, 2020 are not necessarily indicative of the
 results to be expected for the year ending December&amp;#xA0;31, 2020
 or for any future periods.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_8365A760-9C09-4459-A88B-FB2ADE593F77_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company considers all short-term investments with an original
 maturity of three months or less when purchased to be cash
 equivalents. The Company did not have any cash equivalents as of
 September&amp;#xA0;30, 2020 and December&amp;#xA0;31, 2019.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_FE747B95-3F1E-4F8B-BFBD-A527A1704F7F_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Financial instruments that potentially subject the Company to
 concentrations of credit risk consist of a cash account in a
 financial institution which, at times may exceed the Federal
 Depository Insurance Coverage of $250,000. The Company has not
 experienced losses on this account and management believes the
 Company is not exposed to significant risks on such account.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_5A9E29DF-85FA-4414-AD09-F52510EA33A2_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The fair value of the Company&amp;#x2019;s assets and liabilities, which
 qualify as financial instruments under ASC Topic 820, &amp;#x201C;Fair
 Value Measurement,&amp;#x201D; approximates the carrying amounts
 represented in the accompanying condensed balance sheets, primarily
 due to their short-term nature.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_BDD13BD9-AD4F-4681-80CB-17EF84D7D9C9_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;NOTE 8. FAIR VALUE MEASUREMENTS&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company follows the guidance in ASC Topic 820 for its financial
 assets and liabilities that are&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;re-measured&lt;/font&gt;&amp;#xA0;and
 reported at fair value at each reporting period,
 and&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;non-financial&lt;/font&gt;&amp;#xA0;assets
 and liabilities that are&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;re-measured&lt;/font&gt;&amp;#xA0;and
 reported at fair value at least annually.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The fair value of the Company&amp;#x2019;s financial assets and
 liabilities reflects management&amp;#x2019;s estimate of amounts that
 the Company would have received in connection with the sale of the
 assets or paid in connection with the transfer of the liabilities
 in an orderly transaction between market participants at the
 measurement date. In connection with measuring the fair value of
 its assets and liabilities, the Company seeks to maximize the use
 of observable inputs (market data obtained from independent
 sources) and to minimize the use of unobservable inputs (internal
 assumptions about how market participants would price assets and
 liabilities). The following fair value hierarchy is used to
 classify assets and liabilities based on the observable inputs and
 unobservable inputs used in order to value the assets and
 liabilities:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;div style="FONT-SIZE: medium; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" align="right"&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="96%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="8%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td width="91%"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; break-inside: avoid"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Level&amp;#xA0;1:&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Quoted prices in active markets for identical
 assets or liabilities. An active market for an asset or liability
 is a market in which transactions for the asset or liability occur
 with sufficient frequency and volume to provide pricing information
 on an ongoing basis.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;div style="FONT-SIZE: medium; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" align="right"&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="96%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="8%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td width="91%"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; break-inside: avoid"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Level&amp;#xA0;2:&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Observable inputs other than Level&amp;#xA0;1
 inputs. Examples of Level&amp;#xA0;2 inputs include quoted prices in
 active markets for similar assets or liabilities and quoted prices
 for identical assets or liabilities in markets that are not
 active.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;div style="FONT-SIZE: medium; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" align="right"&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="96%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="8%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td width="91%"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; break-inside: avoid"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Level&amp;#xA0;3:&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Unobservable inputs based on our assessment of
 the assumptions that market participants would use in pricing the
 asset or liability.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The following table presents information about the Company&amp;#x2019;s
 assets that are measured at fair value on a recurring basis at
 September&amp;#xA0;30, 2020 and indicates the fair value hierarchy of
 the valuation inputs the Company utilized to determine such fair
 value:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="76%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; break-inside: avoid"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt; DISPLAY: table-cell"&gt;
 Description&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;Level&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;September&amp;#xA0;30,&lt;br /&gt;
 2020&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; break-inside: avoid"&gt;
 &lt;td valign="bottom"&gt;Assets:&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; break-inside: avoid" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Cash and Marketable securities held in Trust Account&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;828,096,607&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_49E1A2F1-B56A-408C-A17C-29084B0B72F6_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 &lt;b&gt;NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS
 OPERATIONS&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 Social Capital Hedosophia Holdings Corp. III (the
 &amp;#x201C;Company&amp;#x201D;) is a blank check company incorporated as a
 Cayman Islands exempted company on October&amp;#xA0;18, 2019. The
 Company was formed for the purpose of effecting a merger, share
 exchange, asset acquisition, share purchase, reorganization or
 similar business combination with one or more businesses (a
 &amp;#x201C;Business Combination&amp;#x201D;).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company is not limited to a particular industry or sector for
 purposes of consummating a Business Combination. The Company is an
 early stage and emerging growth company and, as such, the Company
 is subject to all of the risks associated with early stage and
 emerging growth companies.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company has one subsidiary, Asclepius Merger Sub Inc., a wholly
 owned subsidiary of the Company incorporated in Delaware on
 October&amp;#xA0;1, 2020 (&amp;#x201C;Merger Sub&amp;#x201D;).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 As of September&amp;#xA0;30, 2020, the Company had not commenced any
 operations. All activity for the period from October&amp;#xA0;18, 2019
 (inception) through September&amp;#xA0;30, 2020 relates to the
 Company&amp;#x2019;s formation, the initial public offering
 (&amp;#x201C;Initial Public Offering&amp;#x201D;), which is described below,
 and activities in connection with the search for a Business
 Combination, including the proposed acquisition of Clover Health
 Investments Corp., a Delaware corporation (&amp;#x201C;Clover&amp;#x201D;).
 The Company will not generate any operating revenues until after
 the completion of its initial Business Combination, at the
 earliest. The Company generates&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;non-operating&lt;/font&gt;&amp;#xA0;income
 in the form of interest income from the proceeds derived from the
 Initial Public Offering.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The registration statements for the Company&amp;#x2019;s Initial Public
 Offering became effective on April&amp;#xA0;21, 2020. On April&amp;#xA0;24,
 2020, the Company consummated the Initial Public Offering of
 82,800,000 units (the &amp;#x201C;Units&amp;#x201D; and, with respect to the
 shares of Class&amp;#xA0;A ordinary shares included in the Units sold,
 the &amp;#x201C;Public Shares&amp;#x201D;), which includes the full exercise
 by the underwriters of the over-allotment option to purchase an
 additional 10,800,000 Units, at $10.00 per Unit, generating gross
 proceeds of $828,000,000 which is described in Note 3.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 Simultaneously with the closing of the Initial Public Offering, the
 Company consummated the sale of 10,933,333 warrants (the
 &amp;#x201C;Private Placement Warrants&amp;#x201D;) at a price of $1.50 per
 Private Placement Warrant in a private placement to SCH Sponsor III
 LLC (the &amp;#x201C;Sponsor&amp;#x201D;), generating gross proceeds of
 $16,400,000, which is described in Note 4.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 Transaction costs amounted to $44,156,346 consisting of $14,400,000
 of underwriting fees, $28,980,000 of deferred underwriting fees and
 $776,346 of other offering costs. In addition, at
 September&amp;#xA0;30, 2020, cash of $126,745 was held outside of the
 Trust Account, as defined below, and is available for working
 capital purposes.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 Following the closing of the Initial Public Offering on
 April&amp;#xA0;24, 2020, an amount of $828,000,000 ($10.00 per Unit)
 from the net proceeds of the sale of the Units in the Initial
 Public Offering and the sale of the Private Placement Warrants was
 placed in a trust account (the &amp;#x201C;Trust Account&amp;#x201D;) located
 in the United States and invested in U.S. government securities,
 within the meaning set forth in Section&amp;#xA0;2(a)(16) of the
 Investment Company Act of 1940, as amended (the &amp;#x201C;Investment
 Company Act&amp;#x201D;), with a maturity of 185&amp;#xA0;days or less, or
 in any open-ended investment company that holds itself out as a
 money market fund meeting the conditions
 of&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;Rule&amp;#xA0;2a-7&lt;/font&gt;&amp;#xA0;of
 the Investment Company Act, as determined by the Company, until the
 earlier of: (i)&amp;#xA0;the completion of a Business Combination and
 (ii)&amp;#xA0;the distribution of the funds in the Trust Account to the
 Company&amp;#x2019;s shareholders, as described below.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company will provide the holders of the Public Shares (the
 &amp;#x201C;Public Shareholders&amp;#x201D;) with the opportunity to redeem
 all or a portion of their Public Shares upon the completion of the
 Business Combination, either (i)&amp;#xA0;in connection with a
 shareholder meeting called to approve the Business Combination or
 (ii)&amp;#xA0;by means of a tender offer. The decision as to whether
 the Company will seek shareholder approval of a Business
 Combination or conduct a tender offer will be made by the Company,
 solely in its discretion. The Public Shareholders will be entitled
 to redeem their shares for a pro&amp;#xA0;rata portion of the amount
 held in the Trust Account, calculated as of two business days prior
 to the completion of a Business Combination, including any
 pro&amp;#xA0;rata interest earned on the funds held in the Trust
 Account and not previously released to the Company to pay its tax
 obligations. The&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;per-share&lt;/font&gt;&amp;#xA0;amount to
 be distributed to the Public Shareholders who redeem their shares
 will not be reduced by the deferred underwriting commissions the
 Company will pay to the underwriters (as discussed in Note 6).
 There will be no redemption rights upon the completion of a
 Business Combination with respect to the Company&amp;#x2019;s
 warrants.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company will proceed with a Business Combination only if the
 Company has net tangible assets, after payment of the deferred
 underwriting commission, of at least $5,000,001 upon such
 completion of a Business Combination and, if the Company seeks
 shareholder approval, it receives an ordinary resolution under
 Cayman Islands law approving a Business Combination, which requires
 the affirmative vote of a majority of the shareholders who attend
 and vote at a general meeting of the Company. If a shareholder vote
 is not required and the Company does not decide to hold a
 shareholder vote for business or other legal reasons, the Company
 will, pursuant to its Amended and Restated Memorandum and Articles
 of Association, conduct the redemptions pursuant to the tender
 offer rules&amp;#xA0;of the Securities and Exchange Commission
 (&amp;#x201C;SEC&amp;#x201D;), and file tender offer documents containing
 substantially the same information as would be included in a proxy
 statement with the SEC prior to completing a Business Combination.
 If the Company seeks shareholder approval in connection with a
 Business Combination, the Company&amp;#x2019;s Sponsor has agreed to
 vote its Founder Shares (as defined in Note&amp;#xA0;5) and any Public
 Shares purchased during or after the Initial Public Offering in
 favor of approving a Business Combination and to waive its
 redemption rights with respect to any such shares in connection
 with a shareholder vote to approve a Business Combination or seek
 to sell any shares to the Company in a tender offer in connection
 with a Business Combination. Additionally, subject to the
 immediately succeeding paragraph, each public shareholder may elect
 to redeem their Public Shares, without voting, and if they do vote,
 irrespective of whether they vote for or against a proposed
 Business Combination.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 Notwithstanding the foregoing, if the Company seeks shareholder
 approval of the Business Combination and the Company does not
 conduct redemptions pursuant to the tender offer rules, a Public
 Shareholder, together with any affiliate of such shareholder or any
 other person with whom such shareholder is acting in concert or as
 a &amp;#x201C;group&amp;#x201D; (as defined under Section&amp;#xA0;13 of the
 Securities Exchange Act of 1934, as amended (the &amp;#x201C;Exchange
 Act&amp;#x201D;), will be restricted from redeeming its shares with
 respect to more than 15% of the Public Shares without the
 Company&amp;#x2019;s prior written consent.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Sponsor has agreed (a)&amp;#xA0;to waive its redemption rights with
 respect to any Founder Shares and Public Shares held by it in
 connection with the completion of a Business Combination (and not
 seek to sell its shares to the Company in any tender offer the
 Company undertakes in connection with its initial Business
 Combination) and (b)&amp;#xA0;not to propose an amendment to the
 Amended and Restated Memorandum and Articles of Association
 (i)&amp;#xA0;to modify the substance or timing of the Company&amp;#x2019;s
 obligation to redeem 100% of the Public Shares if the Company does
 not complete a Business Combination within Combination Period (as
 defined below) or (ii)&amp;#xA0;with respect to any other provision
 relating to shareholders&amp;#x2019; rights
 or&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;pre-initial&lt;/font&gt;&amp;#xA0;business
 combination activity, unless the Company provides the public
 shareholders with the opportunity to redeem their Public Shares in
 conjunction with any such amendment.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company will have until April&amp;#xA0;24, 2022 (the
 &amp;#x201C;Combination Period&amp;#x201D;) to consummate a Business
 Combination. However, if the Company has not completed a Business
 Combination within the Combination Period, the Company will
 (i)&amp;#xA0;cease all operations except for the purpose of winding up,
 (ii)&amp;#xA0;as promptly as reasonably possible but not more than ten
 business days thereafter, redeem the public shares, at
 a&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;per-share&lt;/font&gt;&amp;#xA0;price,
 payable in cash, equal to the aggregate amount then on deposit in
 the Trust Account, including interest (which interest shall be net
 of taxes payable, and less up to $100,000 of interest to pay
 dissolution expenses) divided by the number of then outstanding
 public shares, which redemption will completely extinguish the
 rights of the Public Shareholders as shareholders (including the
 right to receive further liquidation distributions, if any),
 subject to applicable law, and (iii)&amp;#xA0;as promptly as reasonably
 possible following such redemption, subject to the approval of the
 Company&amp;#x2019;s remaining Public Shareholders and its Board of
 Directors, liquidate and dissolve, subject in each case to the
 Company&amp;#x2019;s obligations under Cayman Islands law to provide for
 claims of creditors and the requirements of other applicable law.
 In the event of a liquidation, the Public Shareholders will be
 entitled to receive a full pro&amp;#xA0;rata interest in the Trust
 Account ($10.00 per share, plus any pro&amp;#xA0;rata interest earned
 on the Trust Fund not previously released to the Company and less
 up to $100,000 of interest to pay dissolution expenses). There will
 be no redemption rights or liquidating distributions with respect
 to the Founder Shares or the Private Placement Warrants, which will
 expire worthless if the Company fails to complete a Business
 Combination within the Combination Period.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 In order to protect the amounts held in the Trust Account, the
 Sponsor has agreed that it will be liable to the Company, if and to
 the extent any claims by a third party (other than the
 Company&amp;#x2019;s independent auditors) for services rendered or
 products sold to the Company, or a prospective target business with
 which the Company has discussed entering into a transaction
 agreement, reduce the amount of funds in the Trust Account to below
 (1)&amp;#xA0;$10.00 per Public Share or (2)&amp;#xA0;such lesser amount per
 Public Share held in the Trust Account as of the date of the
 liquidation of the Trust Account due to reductions in the value of
 trust assets, in each case net of the interest which may be
 withdrawn to pay taxes, except as to any claims by a third party
 who executed a waiver of any and all rights to seek access to the
 Trust Account and except as to any claims under the Company&amp;#x2019;s
 indemnity of the underwriters of the Initial Public Offering
 against certain liabilities, including liabilities under the
 Securities Act of 1933, as amended (the &amp;#x201C;Securities
 Act&amp;#x201D;). In the event that an executed waiver is deemed to be
 unenforceable against a third party, the Sponsor will not be
 responsible to the extent of any liability for such third-party
 claims. The Company will seek to reduce the possibility that the
 Sponsor will have to indemnify the Trust Account due to claims of
 creditors by endeavoring to have all vendors, service providers
 (other than the Company&amp;#x2019;s independent auditors), prospective
 target businesses or other entities with which the Company does
 business, execute agreements with the Company waiving any right,
 title, interest or claim of any kind in or to monies held in the
 Trust Account.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Liquidity and Going Concern&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 As of September&amp;#xA0;30, 2020, the Company had $126,745 in its
 operating bank accounts, $828,096,607 in securities held in the
 Trust Account to be used for a Business Combination or to
 repurchase or redeem its ordinary shares in connection therewith
 and working capital deficit of $1,215,153. As of September&amp;#xA0;30,
 2020, approximately $97,000 of the amount on deposit in the Trust
 Account represented interest income.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 Until the consummation of a Business Combination, the Company will
 be using the funds not held in the Trust Account for identifying
 and evaluating prospective acquisition candidates, performing due
 diligence on prospective target businesses, paying for travel
 expenditures, selecting the target business to acquire, and
 structuring, negotiating and consummating the Business
 Combination.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 On October&amp;#xA0;19, 2020, the Company issued an unsecured
 promissory note to the Sponsor (the &amp;#x201C;Promissory Note&amp;#x201D;),
 pursuant to which the Company may borrow up to an aggregate
 principal amount of $2,500,000 (see Note&amp;#xA0;9). On
 October&amp;#xA0;19, 2020, the Company borrowed $806,208 under the
 Promissory Note.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company may need to raise additional capital through loans or
 additional investments from its Sponsor, officers, directors, or
 third parties. The Company&amp;#x2019;s officers, directors and Sponsor
 may, but are not obligated to, loan the Company additional funds,
 from time to time or at any time (other than pursuant to the
 Promissory Note), to meet the Company&amp;#x2019;s working capital
 needs. Accordingly, the Company may not be able to obtain
 additional financing. If the Company is unable to raise additional
 capital, it may be required to take additional measures to conserve
 liquidity, which could include, but not necessarily be limited to,
 curtailing operations, suspending the pursuit of a potential
 transaction, and reducing overhead expenses. The Company cannot
 provide any assurance that new financing will be available to it on
 commercially acceptable terms, if at all. These conditions raise
 substantial doubt about the Company&amp;#x2019;s ability to continue as
 a going concern for the next twelve months following the date from
 when the financial statements are issued. These financial
 statements do not include any adjustments relating to the recovery
 of the recorded assets or the classification of the liabilities
 that might be necessary should the Company be unable to continue as
 a going concern.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_CAA23201-685A-4A7F-BDAD-3507E9A68067_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;NOTE 5. RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;Founder Shares&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 In October&amp;#xA0;2019, the Company issued one ordinary share to the
 Sponsor for no consideration. On January&amp;#xA0;21, 2020, the Company
 cancelled the one share issued in October&amp;#xA0;2019 and the Sponsor
 purchased 17,250,000 Founder Shares for an aggregate purchase price
 of $25,000. On April&amp;#xA0;21, 2020, the Company effected a share
 capitalization, resulting in 20,700,000 Founder Shares issued and
 outstanding as of such date. All share
 and&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;per-share&lt;/font&gt;&amp;#xA0;amounts
 have been retroactively restated to reflect the share
 capitalization. The Founder Shares will automatically convert into
 Class&amp;#xA0;A ordinary shares on the first business day following
 the completion of a Business Combination, or earlier at the option
 of the holder, on a&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;&lt;font style="WHITE-SPACE: nowrap"&gt;one-for-one&lt;/font&gt;&lt;/font&gt;&amp;#xA0;basis,
 subject to certain adjustments, as described in Note 7.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Founder Shares included an aggregate of up to 2,700,000 shares
 subject to forfeiture by the Sponsor to the extent that the
 underwriters&amp;#x2019; overallotment was not exercised in full or in
 part, so that the number of Founder Shares would collectively
 represent 20% of the Company&amp;#x2019;s issued and outstanding shares
 upon the completion of the Initial Public Offering. As a result of
 the underwriters&amp;#x2019; election to fully exercise their
 over-allotment option, no Founder Shares are subject to
 forfeiture.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Sponsor has agreed, subject to limited exceptions, not to
 transfer, assign or sell any of its Class&amp;#xA0;B ordinary shares or
 Class&amp;#xA0;A ordinary shares received upon conversion thereof&amp;#xA0;
 (together, &amp;#x201C;Founder Shares&amp;#x201D;) until the earlier of:
 (A)&amp;#xA0;one year after the completion of a Business Combination
 and (B)&amp;#xA0;subsequent to a Business Combination, (x)&amp;#xA0;if the
 last reported sale price of the Class&amp;#xA0;A ordinary shares equals
 or exceeds $12.00 per share (as adjusted for share splits, share
 dividends, rights issuances, subdivisions, reorganizations,
 recapitalizations and the like) for any 20 trading days within
 any&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;30-trading&lt;/font&gt;&amp;#xA0;day
 period commencing at least 150&amp;#xA0;days after a Business
 Combination, or (y)&amp;#xA0;the date on which the Company completes a
 liquidation, merger, amalgamation, share exchange, reorganization
 or other similar transaction that results in all of the
 Company&amp;#x2019;s shareholders having the right to exchange their
 Class&amp;#xA0;A ordinary shares for cash, securities or other
 property.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Advances &amp;#x2014; Related Party&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Sponsor advanced the Company an aggregate of $17,631 to cover
 expenses related to the Initial Public Offering. The advances
 were&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;non-interest&lt;/font&gt;&amp;#xA0;bearing
 and due on demand. Advances in the aggregate amount of $17,631 were
 repaid in February&amp;#xA0;2020.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Promissory Note&amp;#xA0;&amp;#x2014;&amp;#xA0;Related Party&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 On January&amp;#xA0;21, 2020, the Company issued an unsecured
 promissory note to the Sponsor, pursuant to which the Company
 borrowed an aggregate principal amount of $300,000. The note
 was&amp;#xA0;&lt;font style="WHITE-SPACE: nowrap"&gt;non-interest&lt;/font&gt;&amp;#xA0;bearing
 and payable on the earlier of (i)&amp;#xA0;June&amp;#xA0;30, 2020 and
 (ii)&amp;#xA0;the completion of the Initial Public Offering. The
 borrowings outstanding under the note in the amount of $300,000
 were repaid upon the consummation of the Initial Public Offering on
 April&amp;#xA0;24, 2020.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Administrative Support Agreement&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 The Company entered into an agreement whereby, commencing on
 April&amp;#xA0;21, 2020, the Company will pay an affiliate of the
 Sponsor up to $10,000 per month for office space, administrative
 and support services. Upon completion of a Business Combination or
 its liquidation, the Company will cease paying these monthly fees.
 For the three and nine months ended September&amp;#xA0;30, 2020, the
 Company incurred $30,000 and $50,000 of such fees. As of
 September&amp;#xA0;30, 2020, $50,000 is included in accrued expenses in
 the accompanying condensed balance sheets.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Related Party Loans&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 In order to finance transaction costs in connection with a Business
 Combination, the Sponsor or an affiliate of the Sponsor, or certain
 of the Company&amp;#x2019;s officers and directors may, but are not
 obligated to (other than pursuant to the Promissory Note), loan the
 Company additional funds as may be required (&amp;#x201C;Working Capital
 Loans&amp;#x201D;). Such Working Capital Loans would be evidenced by
 promissory notes. The notes may be repaid upon completion of a
 Business Combination, without interest, or, at the lender&amp;#x2019;s
 discretion, up to $1,500,000 of notes may be converted upon
 completion of a Business Combination into warrants at a price of
 $1.50 per warrant. Such warrants would be identical to the Private
 Placement Warrants. In the event that a Business Combination does
 not close, the Company may use a portion of proceeds held outside
 the Trust Account to repay the Working Capital Loans but no
 proceeds held in the Trust Account would be used to repay the
 Working Capital Loans.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <ipoc:PublicOfferingDisclosureTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_906B8D26-FBF9-4C23-91F4-92B6E8F5DFC5_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;NOTE 3. INITIAL PUBLIC OFFERING&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 Pursuant to the Initial Public Offering, the Company sold
 82,800,000 Units, which includes the full exercise by the
 underwriter of its option to purchase an additional 10,800,000
 Units, at a purchase price of $10.00 per Unit. Each Unit consists
 of one Class&amp;#xA0;A ordinary share and &lt;font style="white-space:nowrap"&gt;one-third&lt;/font&gt; of one redeemable warrant
 (&amp;#x201C;Public Warrant&amp;#x201D;). Each whole Public Warrant entitles
 the holder to purchase one Class&amp;#xA0;A ordinary share at an
 exercise price of $11.50 per whole share (see Note 7).&lt;/p&gt;
 &lt;/div&gt;</ipoc:PublicOfferingDisclosureTextBlock>
  <ipoc:RisksAndUncertaintiesPolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_A676A520-7ADE-4F98-958A-0783E2D5F358_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Risks and Uncertainties&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Management continues to evaluate the impact of the &lt;font style="WHITE-SPACE: nowrap"&gt;COVID-19&lt;/font&gt; pandemic and has concluded
 that while it is reasonably possible that the virus could have a
 negative effect on the Company&amp;#x2019;s financial position, results
 of its operations and/or search for a target company, the specific
 impact is not readily determinable as of the date of these
 financial statements. The financial statements do not include any
 adjustments that might result from the outcome of this
 uncertainty.&lt;/p&gt;
 &lt;/div&gt;</ipoc:RisksAndUncertaintiesPolicyTextBlock>
  <ipoc:PrivatePlacementDisclosureTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_BC9A49A6-3BCD-4FE4-BA85-C22534183229_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;NOTE 4. PRIVATE PLACEMENT&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;

 Simultaneously with the closing of the Initial Public Offering, the
 Sponsor purchased an aggregate of 10,933,333 Private Placement
 Warrants at a price of $1.50 per Private Placement Warrant, for an
 aggregate purchase price of $16,400,000. Each Private Placement
 Warrant is exercisable for one Class&amp;#xA0;A ordinary share at a
 price of $11.50 per share, subject to adjustment (see Note 7). The
 proceeds from the sale of the Private Placement Warrants were added
 to the net proceeds from the Initial Public Offering held in the
 Trust Account. If the Company does not complete a Business
 Combination within the Combination Period, the proceeds from the
 sale of the Private Placement Warrants held in the Trust Account
 will be used to fund the redemption of the Public Shares (subject
 to the requirements of applicable law) and the Private Placement
 Warrants will expire worthless.&lt;/p&gt;
 &lt;/div&gt;</ipoc:PrivatePlacementDisclosureTextBlock>
  <ipoc:CompanyGrowthPolicyPolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_06E5972B-3859-4159-A5D5-EF27F0F77FFC_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Emerging Growth Company&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company is an &amp;#x201C;emerging growth company,&amp;#x201D; as defined
 in Section&amp;#xA0;2(a)&amp;#xA0;of the Securities Act, as modified by the
 Jumpstart Our Business Startups Act of 2012 (the &amp;#x201C;JOBS
 Act&amp;#x201D;), and it may take advantage of certain exemptions from
 various reporting requirements that are applicable to other public
 companies that are not emerging growth companies including, but not
 limited to, not being required to comply with the independent
 registered public accounting firm attestation requirements of
 Section&amp;#xA0;404 of the Sarbanes-Oxley Act, reduced disclosure
 obligations regarding executive compensation in its periodic
 reports and proxy statements, and exemptions from the requirements
 of holding a nonbinding advisory vote on executive compensation and
 shareholder approval of any golden parachute payments not
 previously approved.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 Further, Section&amp;#xA0;102(b)(1)&amp;#xA0;of the JOBS Act exempts
 emerging growth companies from being required to comply with new or
 revised financial accounting standards until private companies
 (that is, those that have not had a Securities Act registration
 statement declared effective or do not have a class of securities
 registered under the Exchange Act) are required to comply with the
 new or revised financial accounting standards. The JOBS Act
 provides that a company can elect to opt out of the extended
 transition period and comply with the requirements that apply to
 &lt;font style="WHITE-SPACE: nowrap"&gt;non-emerging&lt;/font&gt; growth
 companies but any such election to opt out is irrevocable. The
 Company has elected not to opt out of such extended transition
 period which means that when a standard is issued or revised and it
 has different application dates for public or private companies,
 the Company, as an emerging growth company, can adopt the new or
 revised standard at the time private companies adopt the new or
 revised standard. This may make comparison of the Company&amp;#x2019;s
 financial statements with another public company which is neither
 an emerging growth company nor an emerging growth company which has
 opted out of using the extended transition period difficult or
 impossible because of the potential differences in accounting
 standards used.&lt;/p&gt;
 &lt;/div&gt;</ipoc:CompanyGrowthPolicyPolicyTextBlock>
  <ipoc:CashAndMarketableSecuritiesHeldInTrustAccountPolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_2C14258B-2A39-4ED9-91A4-98F2C2787B9B_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Cash and Marketable Securities Held in Trust Account&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 At September&amp;#xA0;30, 2020, the assets held in the Trust Account
 were primarily invested in money market funds, which invest in U.S.
 Treasury securities.&lt;/p&gt;
 &lt;/div&gt;</ipoc:CashAndMarketableSecuritiesHeldInTrustAccountPolicyTextBlock>
  <ipoc:CommonStockSubjectToPossibleRedemptionPolicyPolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_274_20200930_0" id="id_10882567_45C328C6-FFEE-49EA-BE3D-71D8B2927443_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Class&amp;#xA0;A Ordinary Shares Subject to Possible
 Redemption&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company accounts for its Class&amp;#xA0;A ordinary shares subject
 to possible redemption in accordance with the guidance in
 Accounting Standards Codification (&amp;#x201C;ASC&amp;#x201D;) Topic 480
 &amp;#x201C;Distinguishing Liabilities from Equity.&amp;#x201D; Class&amp;#xA0;A
 ordinary shares subject to mandatory redemption are classified as a
 liability instrument and are measured at fair value. Conditionally
 redeemable ordinary shares (including ordinary shares that feature
 redemption rights that are either within the control of the holder
 or subject to redemption upon the occurrence of uncertain events
 not solely within the Company&amp;#x2019;s control) are classified as
 temporary equity. At all other times, ordinary shares are
 classified as shareholders&amp;#x2019; equity. The Company&amp;#x2019;s
 Class&amp;#xA0;A ordinary shares feature certain redemption rights that
 are considered to be outside of the Company&amp;#x2019;s control and
 subject to occurrence of uncertain future events. Accordingly,
 Class&amp;#xA0;A ordinary shares subject to possible redemption are
 presented at redemption value as temporary equity, outside of the
 shareholders&amp;#x2019; equity section of the Company&amp;#x2019;s condensed
 balance sheets.&lt;/p&gt;
 &lt;/div&gt;</ipoc:CommonStockSubjectToPossibleRedemptionPolicyPolicyTextBlock>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_CEAC836B-ED04-47F7-9E42-A5B7F2E16F8A_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Net loss per share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 Net loss per share is computed by dividing net loss by the weighted
 average number of ordinary shares outstanding during the period,
 excluding ordinary shares subject to forfeiture. At
 December&amp;#xA0;31, 2019, the Company did not have any dilutive
 securities and other contracts that could, potentially, be
 exercised or converted into ordinary shares and then share in the
 earnings of the Company. As a result, diluted loss per share is the
 same as basic loss per share for the periods presented.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_D796676A-6007-463B-8BDC-63722BB80AD9_1_7" unitRef="iso4217_USD">17631</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_B76BF330-AC20-4FAA-9CFB-7FC79D13F5F0_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 7&amp;#xA0;&amp;#x2014;&amp;#xA0;Shareholder&amp;#x2019;s Equity&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 &lt;b&gt;&lt;i&gt;Preferred Shares&lt;/i&gt;&lt;/b&gt;&amp;#xA0;&amp;#x2014;&amp;#xA0;The Company is
 authorized to issue 5,000,000 preference shares with a par value of
 $0.0001. The Company&amp;#x2019;s board of directors will be authorized
 to fix the voting rights, if any, designations, powers,
 preferences, the relative, participating, optional or other special
 rights and any qualifications, limitations and restrictions
 thereof, applicable to the shares of each series. The board of
 directors will be able to, without shareholder approval, issue
 preferred shares with voting and other rights that could adversely
 affect the voting power and other rights of the holders of the
 ordinary shares and could have anti-takeover effects. At
 December&amp;#xA0;31, 2019, there were no preference shares issued or
 outstanding.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 &lt;b&gt;&lt;i&gt;Class&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;&amp;#xA0;A Ordinary
 Shares&lt;/i&gt;&lt;/b&gt;&amp;#xA0;&amp;#x2014;&amp;#xA0;The Company is authorized to issue
 500,000,000 Class&amp;#xA0;A ordinary shares, with a par value of
 $0.0001 per share. Holders of Class&amp;#xA0;A ordinary shares are
 entitled to one vote for each share. At December&amp;#xA0;31, 2019,
 there were no Class&amp;#xA0;A ordinary shares issued or
 outstanding.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 &lt;b&gt;&lt;i&gt;Class&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;&amp;#xA0;B Ordinary
 Shares&lt;/i&gt;&lt;/b&gt;&amp;#xA0;&amp;#x2014;&amp;#xA0;The Company is authorized to issue
 50,000,000 Class&amp;#xA0;B ordinary shares, with a par value of
 $0.0001 per share. Holders of the Class&amp;#xA0;B ordinary shares are
 entitled to one vote for each share. At December&amp;#xA0;31, 2019,
 there was one Class&amp;#xA0;B ordinary share issued and
 outstanding.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 Only holders of the Class&amp;#xA0;B ordinary shares will have the
 right to vote on the election of directors prior to the Business
 Combination. Holders of Class&amp;#xA0;A ordinary shares and holders of
 Class&amp;#xA0;B ordinary shares will vote together as a single class
 on all matters submitted to a vote of our shareholders except as
 otherwise required by law.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 The Class&amp;#xA0;B Shares will automatically convert into
 Class&amp;#xA0;A ordinary shares on the first business day following
 the completion of the Business Combination, or earlier at the
 option of the holder, on a &lt;font style="WHITE-SPACE: nowrap"&gt;&lt;font style="WHITE-SPACE: nowrap"&gt;one-for-one&lt;/font&gt;&lt;/font&gt; basis, subject to
 adjustment. In the case that additional Class&amp;#xA0;A ordinary
 shares, or equity-linked securities, are issued or deemed issued in
 excess of the amounts issued in the Proposed Public Offering and
 related to the closing of a Business Combination, the ratio at
 which Founder Shares will convert into Class&amp;#xA0;A ordinary shares
 will be adjusted (subject to waiver by holders of a majority of the
 Class&amp;#xA0;B ordinary shares) so that the number of Class&amp;#xA0;A
 ordinary shares issuable upon conversion of all Founder Shares will
 equal, in the aggregate, on an &lt;font style="WHITE-SPACE: nowrap"&gt;as-converted&lt;/font&gt; basis, 20% of the sum of
 the ordinary shares issued and outstanding upon completion of the
 Proposed Public Offering plus the number of Class&amp;#xA0;A ordinary
 shares and equity-linked securities issued or deemed issued in
 connection with a Business Combination (net of redemptions),
 excluding any Class&amp;#xA0;A ordinary shares or equity-linked
 securities issued, or to be issued, to any seller in a Business
 Combination and any Private Placement Warrants issued to the
 Sponsor.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 &lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&amp;#xA0;&amp;#x2014;&amp;#xA0;Public Warrants may only
 be exercised for a whole number of shares. No fractional shares
 will be issued upon exercise of the Public Warrants. The Public
 Warrants will become exercisable on the later of
 (a)&amp;#xA0;30&amp;#xA0;days after the completion of a Business
 Combination and (b)&amp;#xA0;12&amp;#xA0;months from the closing of the
 Proposed Public Offering. The Public Warrants will expire
 five&amp;#xA0;years from the completion of a Business Combination or
 earlier upon redemption or liquidation.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 The Company will not be obligated to deliver any Class&amp;#xA0;A
 ordinary shares pursuant to the exercise of a Public Warrant and
 will have no obligation to settle such Public Warrant exercise
 unless a registration statement under the Securities Act covering
 the issuance of the Class&amp;#xA0;A ordinary shares issuable upon
 exercise of the Public Warrants is then effective and a prospectus
 relating thereto is current, subject to the Company satisfying its
 obligations with respect to registration. No Public Warrant will be
 exercisable for cash or on a cashless basis, and the Company will
 not be obligated to issue any shares to holders seeking to exercise
 their Public Warrants, unless the issuance of the shares upon such
 exercise is registered or qualified under the securities laws of
 the state of the exercising holder, or an exemption from
 registration is available.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 The Company has agreed that as soon as practicable, but in no event
 later than 15 business days, after the closing of a Business
 Combination, it will use its commercially reasonable efforts to
 file with the SEC a registration statement registering the
 issuance, under the Securities Act, of the Class&amp;#xA0;A ordinary
 shares issuable upon exercise of the Public Warrants. The Company
 will use it commercially reasonable efforts to cause the same to
 become effective within 60 business days after the closing of the
 Business Combination and to maintain the effectiveness of such
 registration statement, and a current prospectus relating thereto,
 until the expiration of the Public Warrants in accordance with the
 provisions of the warrant agreement. Notwithstanding the above, if
 the Class&amp;#xA0;A ordinary shares are, at the time of any exercise
 of a Public Warrant, not listed on a national securities exchange
 such that they satisfy the definition of a &amp;#x201C;covered
 security&amp;#x201D; under Section&amp;#xA0;18(b)(1) of the Securities Act,
 the Company may, at its option, require holders of Public Warrants
 who exercise their Public Warrants to do so on a &amp;#x201C;cashless
 basis&amp;#x201D; in accordance with Section&amp;#xA0;3(a)(9) of the
 Securities Act and, in the event the Company so elects, the Company
 will not be required to file or maintain in effect a registration
 statement, but will use its commercially reasonable efforts to
 qualify the shares under applicable blue sky laws to the extent an
 exemption is not available.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 &lt;i&gt;Redemption of warrants when the price per Class&lt;/i&gt;&lt;i&gt;&amp;#xA0;A
 ordinary share equals or exceeds $18.00.&lt;/i&gt; Once the Public
 Warrants become exercisable, the Company may redeem the Public
 Warrants:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;in whole and not in part;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;at a price of $0.01 per Public Warrant;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;upon not less than 30&amp;#xA0;days&amp;#x2019; prior written
 notice of redemption to each warrant holder and&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;if, and only if, the reported last sale price of the
 Class&amp;#xA0;A ordinary shares for any 20 trading days within a
 &lt;font style="WHITE-SPACE: nowrap"&gt;30-trading&lt;/font&gt; day period
 ending on the third trading day prior to the date on which the
 Company sends the notice of redemption to the warrant holders (the
 &amp;#x201C;Reference Value&amp;#x201D;) equals or exceeds $18.00 per share
 (as adjusted for share splits, share dividends, rights issuances,
 subdivisions, reorganizations, recapitalizations and the like).&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 &lt;i&gt;Redemption of warrants when the price per Class&lt;/i&gt;&lt;i&gt;&amp;#xA0;A
 ordinary share equals or exceeds $10.00.&lt;/i&gt; Once the Public
 Warrants become exercisable, the Company may redeem the Public
 Warrants:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;in whole and not in part;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;at $0.10 per warrant upon a minimum of 30 days&amp;#x2019;
 prior written notice of redemption provided that holders will be
 able to exercise their warrants on a cashless basis prior to
 redemption and receive that number of shares determined by
 reference to the table below, based on the redemption date and the
 &amp;#x201C;fair market value&amp;#x201D; of the Class&amp;#xA0;A ordinary
 shares;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;if, and only if, the Reference Value equals or exceeds
 $10.00 per share (as adjusted for share splits, share dividends,
 rights issuances, subdivisions, reorganizations, recapitalizations
 and the like); and&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;if the Reference Value is less than $18.00 per share
 (as adjusted for share splits, share dividends, rights issuances,
 subdivisions, reorganizations, recapitalizations and the like) the
 Private Placement Warrants must also be concurrently called for
 redemption on the same terms as the outstanding Public Warrants, as
 described above.&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 If and when the Public Warrants become redeemable by the Company,
 the Company may exercise its redemption right even if it is unable
 to register or qualify the underlying securities for sale under all
 applicable state securities laws.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 The exercise price and number of ordinary shares issuable upon
 exercise of the Public Warrants may be adjusted in certain
 circumstances including in the event of a share dividend,
 extraordinary dividend or recapitalization, reorganization, merger
 or consolidation. However, the Public Warrants will not be adjusted
 for issuances of ordinary shares at a price below its exercise
 price. Additionally, in no event will the Company be required to
 net cash settle the Public Warrants. If the Company is unable to
 complete a Business Combination within the Combination Period and
 the Company liquidates the funds held in the Trust Account, holders
 of Public Warrants will not receive any of such funds with respect
 to their Public Warrants, nor will they receive any distribution
 from the Company&amp;#x2019;s assets held outside of the Trust Account
 with respect to such Public Warrants. Accordingly, the Public
 Warrants may expire worthless.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 In addition, if (x)&amp;#xA0;the Company issues additional Class&amp;#xA0;A
 ordinary shares or equity-linked securities for capital raising
 purposes in connection with the closing of a Business Combination
 at an issue price or effective issue price of less than $9.20 per
 Class&amp;#xA0;A ordinary share (with such issue price or effective
 issue price to be determined in good faith by the Company&amp;#x2019;s
 board of directors, and in the case of any such issuance to the
 Sponsor or its affiliates, without taking into account any Founder
 Shares held by the Sponsor or such affiliates, as applicable, prior
 to such issuance) (the &amp;#x201C;Newly Issued Price&amp;#x201D;),
 (y)&amp;#xA0;the aggregate gross proceeds from such issuances represent
 more than 60% of the total equity proceeds, and interest thereon,
 available for the funding of a Business Combination on the date of
 the completion of a Business Combination (net of redemptions), and
 (z)&amp;#xA0;the volume weighted average trading price of the
 Company&amp;#x2019;s ordinary shares during the 20 trading day period
 starting on the trading day prior to the day on which the Company
 consummates a Business Combination (such price, the &amp;#x201C;Market
 Value&amp;#x201D;) is below $9.20 per share, the exercise price of the
 Public Warrants will be adjusted (to the nearest cent) to be equal
 to 115% of the higher of the Market Value and the Newly Issued
 Price, and the $18.00 per share redemption trigger prices described
 above will be adjusted (to the nearest cent) to be equal to 180% of
 the higher of the Market Value and the Newly Issued Price.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 The Private Placement Warrants will be identical to the Public
 Warrants underlying the Units being sold in the Proposed Public
 Offering, except that the Private Placement Warrants and the
 Class&amp;#xA0;A ordinary shares issuable upon the exercise of the
 Private Placement Warrants will not be transferable, assignable or
 salable until 30&amp;#xA0;days after the completion of a Business
 Combination, subject to certain limited exceptions.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 Additionally, the Private Placement Warrants will be exercisable on
 a cashless basis and be &lt;font style="WHITE-SPACE: nowrap"&gt;non-redeemable&lt;/font&gt; as described above so
 long as they are held by the initial purchasers or their permitted
 transferees. If the Private Placement Warrants are held by someone
 other than the initial purchasers or their permitted transferees,
 the Private Placement Warrants will be redeemable by the Company
 and exercisable by such holders on the same basis as the Public
 Warrants.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_16D99B35-C075-4A78-8FCD-F0DF0E0CFB30_1_1" unitRef="iso4217_USD">-17631</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_16D99B35-C075-4A78-8FCD-F0DF0E0CFB30_1_3" unitRef="iso4217_USD_per_shares">-17631</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_63C56F82-BA44-4CF0-9837-439608317AA3_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 6 &amp;#x2014; Commitments&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;&lt;i&gt;Registration Rights&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The holders of the Founder Shares, Private Placement Warrants and
 any warrants that may be issued on conversion of Working Capital
 Loans (and any Class&amp;#xA0;A ordinary shares issuable upon the
 exercise of the Private Placement Warrants or warrants issued upon
 conversion of the Working Capital Loans and upon conversion of the
 Founder Shares) will be entitled to registration rights pursuant to
 a registration rights agreement to be signed prior to or on the
 effective date of the Propose Public Offering requiring the Company
 to register such securities for resale (in the case of the Founder
 Shares, only after conversion to the Company&amp;#x2019;s Class&amp;#xA0;A
 ordinary shares). The holders of these securities will be entitled
 to make up to three demands, excluding short form registration
 demands, that the Company register such securities. In addition,
 the holders have certain &amp;#x201C;piggy-back&amp;#x201D; registration
 rights with respect to registration statements filed subsequent to
 the completion of a Business Combination and rights to require the
 Company to register for resale such securities pursuant to
 Rule&amp;#xA0;415 under the Securities Act. However, the registration
 rights agreement provides that the Company will not be required to
 effect or permit any registration or cause any registration
 statement to become effective until termination of the applicable
 &lt;font style="WHITE-SPACE: nowrap"&gt;lock-up&lt;/font&gt; period. The
 Company will bear the expenses incurred in connection with the
 filing of any such registration statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Underwriting Agreement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The Company will grant the underwriters a &lt;font style="WHITE-SPACE: nowrap"&gt;45-day&lt;/font&gt; option to purchase up to
 10,800,000 additional Units to cover over-allotments at the
 Proposed Public Offering price, less the underwriting discounts and
 commissions.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 The underwriters will be entitled to a cash underwriting discount
 of $14,400,000 in the aggregate, payable upon the closing of the
 Proposed Public Offering. In addition, the underwriters will be
 entitled to a deferred fee of $0.35 per Unit, or $25,200,000 in the
 aggregate (or $28,980,000 in the aggregate if the
 underwriters&amp;#x2019; over-allotment option is exercised in full).
 The deferred fee will become payable to the underwriters from the
 amounts held in the Trust Account solely in the event that the
 Company completes a Business Combination, subject to the terms of
 the underwriting agreement.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Financial Advisory Fee&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The Company intends to engage Connaught (UK) Limited
 (&amp;#x201C;Connaught&amp;#x201D;) to provide financial advisory services in
 connection with the Proposed Public Offering. The Company will pay
 Connaught a fee in an amount equal to 10% of the underwriting
 commission payable to the underwriters. The fee to Connaught will
 be paid in part at the closing of the Proposed Public Offering and
 in part at the closing of the Business Combination, in the same
 proportion as the &lt;font style="WHITE-SPACE: nowrap"&gt;non-deferred&lt;/font&gt; and deferred underwriting
 commission payable to the underwriters. The underwriters have
 agreed to reimburse the Company for the fee to Connaught as it
 becomes payable out of the underwriting commission.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_D796676A-6007-463B-8BDC-63722BB80AD9_1_2" unitRef="iso4217_USD">-17631</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_ACEF1C61-E8FF-42F6-AC2B-510E2EE59509_1_2" unitRef="iso4217_USD">25200000</us-gaap:BusinessCombinationConsiderationTransferred1>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_AFA358C2-AEF1-40D2-A158-5F29EECE6183_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 Management does not believe that any recently issued, but not yet
 effective, accounting standards if currently adopted would have a
 material effect on the accompanying financial statements.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:UseOfEstimates contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_09C7685F-BEE8-4A65-A595-3872FE9F90B2_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Use of estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The preparation of financial statements in conformity with GAAP
 requires management to make estimates and assumptions that affect
 the reported amounts of assets and liabilities and disclosure of
 contingent assets and liabilities at the date of the financial
 statements and the reported amounts of revenues and expenses during
 the reporting period.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 Making estimates requires management to exercise significant
 judgment. It is at least reasonably possible that the estimate of
 the effect of a condition, situation or set of circumstances that
 existed at the date of the financial statements, which management
 considered in formulating its estimate, could change in the near
 term due to one or more future confirming events. Accordingly, the
 actual results could differ significantly from those estimates.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_0F765349-6691-473E-8315-FF5AFE9F3FB1_1_0" unitRef="iso4217_USD">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:CostOfTrustAssetsSoldToPayExpenses contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_A610E5F2-0F8A-461D-ACF7-138476F26E28_1_1" unitRef="iso4217_USD">100000</us-gaap:CostOfTrustAssetsSoldToPayExpenses>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_16D99B35-C075-4A78-8FCD-F0DF0E0CFB30_1_2" unitRef="shares">1</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_70049CDC-E75A-4C78-A856-BB29E773C6DB_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The Company accounts for income taxes under ASC 740, &amp;#x201C;Income
 Taxes&amp;#x201D; (&amp;#x201C;ASC 740&amp;#x201D;). ASC 740 requires the
 recognition of deferred tax assets and liabilities for both the
 expected impact of differences between the financial statement and
 tax basis of assets and liabilities and for the expected future tax
 benefit to be derived from tax loss and tax credit carry forwards.
 ASC 740 additionally requires a valuation allowance to be
 established when it is more likely than not that all or a portion
 of deferred tax assets will not be realized.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 ASC 740 also clarifies the accounting for uncertainty in income
 taxes recognized in an enterprise&amp;#x2019;s financial statements and
 prescribes a recognition threshold and measurement process for
 financial statement recognition and measurement of a tax position
 taken or expected to be taken in a tax return. For those benefits
 to be recognized, a tax position must be &lt;font style="WHITE-SPACE: nowrap"&gt;more-likely-than-not&lt;/font&gt; to be sustained
 upon examination by taxing authorities. The Company recognizes
 accrued interest and penalties related to unrecognized tax benefits
 as income tax expense. There were no unrecognized tax benefits and
 no amounts accrued for interest and penalties as of
 December&amp;#xA0;31, 2019. The Company is currently not aware of any
 issues under review that could result in significant payments,
 accruals or material deviation from its position. The Company is
 subject to income tax examinations by major taxing authorities
 since inception.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 The Company is considered an exempted Cayman Islands Company and is
 presently not subject to income taxes or income tax filing
 requirements in the Cayman Islands or the United States. As such,
 the Company&amp;#x2019;s tax provision was zero for the periods
 presented.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:ProfitLoss contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_D796676A-6007-463B-8BDC-63722BB80AD9_1_1" unitRef="iso4217_USD">-17631</us-gaap:ProfitLoss>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_32AAB061-ED60-47AC-AC73-48A4EEDA9AAC_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Note 2 &amp;#x2014; Significant Accounting Policies&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The accompanying financial statements have been prepared in
 accordance with accounting principles generally accepted in the
 United States of America (&amp;#x201C;US GAAP&amp;#x201D;) and pursuant to
 the accounting and disclosure rules and regulations of the SEC.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Emerging growth company&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The Company is an &amp;#x201C;emerging growth company,&amp;#x201D; as defined
 in Section&amp;#xA0;2(a) of the Securities Act, as modified by the
 Jumpstart Our Business Startups Act of 2012 (the &amp;#x201C;JOBS
 Act&amp;#x201D;), and it may take advantage of certain exemptions from
 various reporting requirements that are applicable to other public
 companies that are not emerging growth companies including, but not
 limited to, not being required to comply with the auditor
 attestation requirements of Section&amp;#xA0;404 of the Sarbanes-Oxley
 Act, reduced disclosure obligations regarding executive
 compensation in its periodic reports and proxy statements, and
 exemptions from the requirements of holding a nonbinding advisory
 vote on executive compensation and shareholder approval of any
 golden parachute payments not previously approved.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 Further, Section&amp;#xA0;102(b)(1) of the JOBS Act exempts emerging
 growth companies from being required to comply with new or revised
 financial accounting standards until private companies (that is,
 those that have not had a Securities Act registration statement
 declared effective or do not have a class of securities registered
 under the Exchange Act) are required to comply with the new or
 revised financial accounting standards. The JOBS Act provides that
 a company can elect to opt out of the extended transition period
 and comply with the requirements that apply to &lt;font style="WHITE-SPACE: nowrap"&gt;non-emerging&lt;/font&gt; growth companies but any
 such election to opt out is irrevocable. The Company has elected
 not to opt out of such extended transition period which means that
 when a standard is issued or revised and it has different
 application dates for public or private companies, the Company, as
 an emerging growth company, can adopt the new or revised standard
 at the time private companies adopt the new or revised standard.
 This may make comparison of the Company&amp;#x2019;s financial
 statements with another public company which is neither an emerging
 growth company nor an emerging growth company which has opted out
 of using the extended transition period difficult or impossible
 because of the potential differences in accounting standards
 used.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Use of estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The preparation of financial statements in conformity with GAAP
 requires management to make estimates and assumptions that affect
 the reported amounts of assets and liabilities and disclosure of
 contingent assets and liabilities at the date of the financial
 statements and the reported amounts of revenues and expenses during
 the reporting period.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 Making estimates requires management to exercise significant
 judgment. It is at least reasonably possible that the estimate of
 the effect of a condition, situation or set of circumstances that
 existed at the date of the financial statements, which management
 considered in formulating its estimate, could change in the near
 term due to one or more future confirming events. Accordingly, the
 actual results could differ significantly from those estimates.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Cash and cash equivalents&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The Company considers all short-term investments with an original
 maturity of three&amp;#xA0;months or less when purchased to be cash
 equivalents. The Company did not have any cash equivalents as of
 December&amp;#xA0;31, 2019.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 18pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;&lt;i&gt;Deferred offering costs&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 Deferred offering costs consist of underwriting, legal, accounting
 and other expenses incurred through the balance sheet date that are
 directly related to the Proposed Public Offering and that will be
 charged to shareholder&amp;#x2019;s equity upon the completion of the
 Proposed Public Offering. Should the Proposed Public Offering prove
 to be unsuccessful, these deferred costs, as well as additional
 expenses incurred, will be charged to operations.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The Company accounts for income taxes under ASC 740, &amp;#x201C;Income
 Taxes&amp;#x201D; (&amp;#x201C;ASC 740&amp;#x201D;). ASC 740 requires the
 recognition of deferred tax assets and liabilities for both the
 expected impact of differences between the financial statement and
 tax basis of assets and liabilities and for the expected future tax
 benefit to be derived from tax loss and tax credit carry forwards.
 ASC 740 additionally requires a valuation allowance to be
 established when it is more likely than not that all or a portion
 of deferred tax assets will not be realized.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 ASC 740 also clarifies the accounting for uncertainty in income
 taxes recognized in an enterprise&amp;#x2019;s financial statements and
 prescribes a recognition threshold and measurement process for
 financial statement recognition and measurement of a tax position
 taken or expected to be taken in a tax return. For those benefits
 to be recognized, a tax position must be &lt;font style="WHITE-SPACE: nowrap"&gt;more-likely-than-not&lt;/font&gt; to be sustained
 upon examination by taxing authorities. The Company recognizes
 accrued interest and penalties related to unrecognized tax benefits
 as income tax expense. There were no unrecognized tax benefits and
 no amounts accrued for interest and penalties as of
 December&amp;#xA0;31, 2019. The Company is currently not aware of any
 issues under review that could result in significant payments,
 accruals or material deviation from its position. The Company is
 subject to income tax examinations by major taxing authorities
 since inception.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 The Company is considered an exempted Cayman Islands Company and is
 presently not subject to income taxes or income tax filing
 requirements in the Cayman Islands or the United States. As such,
 the Company&amp;#x2019;s tax provision was zero for the periods
 presented.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Net loss per share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 Net loss per share is computed by dividing net loss by the weighted
 average number of ordinary shares outstanding during the period,
 excluding ordinary shares subject to forfeiture. At
 December&amp;#xA0;31, 2019, the Company did not have any dilutive
 securities and other contracts that could, potentially, be
 exercised or converted into ordinary shares and then share in the
 earnings of the Company. As a result, diluted loss per share is the
 same as basic loss per share for the periods presented.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Concentration of credit risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 Financial instruments that potentially subject the Company to
 concentrations of credit risk consist of cash accounts in a
 financial institution, which, at times may exceed the Federal
 Depository Insurance Coverage of $250,000. The Company has not
 experienced losses on these accounts and management believes the
 Company is not exposed to significant risks on such accounts.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Fair value of financial instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The fair value of the Company&amp;#x2019;s assets and liabilities, which
 qualify as financial instruments under ASC Topic 820, &amp;#x201C;Fair
 Value Measurements and Disclosures,&amp;#x201D; approximates the
 carrying amounts represented in the accompanying balance sheets,
 primarily due to their short-term nature.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 18pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 Management does not believe that any recently issued, but not yet
 effective, accounting standards if currently adopted would have a
 material effect on the accompanying financial statements.&lt;/p&gt;


 &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:SubsequentEventsTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_73CE0F58-2B08-48EC-8E2E-03CE31F3887C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 8&amp;#xA0;&amp;#x2014;&amp;#xA0;Subsequent Events&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The Company evaluated subsequent events and transactions that
 occurred after the balance sheet date up to January&amp;#xA0;31, 2020,
 the date that the financial statements were available to be issued.
 Other than as described below, the Company did not identify any
 subsequent events that would have required adjustment or disclosure
 in the financial statements.&lt;/p&gt;
 &lt;h5 align="left"&gt;Table of Contents&lt;/h5&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 18pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;&lt;i&gt;Founder Shares&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 On January&amp;#xA0;21, 2020, the Company cancelled the one share
 issued in October&amp;#xA0;2019 and the Sponsor purchased 17,250,000
 Founder Shares for an aggregate purchase price of $25,000. On
 April&amp;#xA0;21, 2020, the Company effected a share capitalization,
 resulting in 20,700,000 Founder Shares issued and outstanding as of
 such date. The Founder Shares will automatically convert into
 Class&amp;#xA0;A ordinary shares on the first business day following
 the completion of a Business Combination on a &lt;font style="WHITE-SPACE: nowrap"&gt;&lt;font style="WHITE-SPACE: nowrap"&gt;one-for-one&lt;/font&gt;&lt;/font&gt; basis, subject to
 certain adjustments, as described in Note 7.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 The Founder Shares include an aggregate of up to 2,700,000 shares
 subject to forfeiture by the Sponsor to the extent that the
 underwriters&amp;#x2019; over-allotment is not exercised in full or in
 part, so that the number of Founder Shares will collectively
 represent 20% of the Company&amp;#x2019;s issued and outstanding shares
 upon the completion of the Proposed Public Offering.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Promissory Note&amp;#xA0;&amp;#x2014;&amp;#xA0;Related Party&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 On January&amp;#xA0;21, 2020, the Company issued an unsecured
 promissory note to the Sponsor, pursuant to which the Company may
 borrow up to an aggregate principal amount of $300,000, of which
 $300,000 was outstanding under the Promissory Note as of
 January&amp;#xA0;21, 2020. The note is &lt;font style="WHITE-SPACE: nowrap"&gt;non-interest&lt;/font&gt; bearing and payable on
 the earlier of (i)&amp;#xA0;June&amp;#xA0;30, 2020 and (ii)&amp;#xA0;the
 completion of the Proposed Public Offering.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 As a result of the execution of the underwriting agreement on
 April&amp;#xA0;21, 2020, the financial statements have been modified to
 reflect the final terms of the agreement.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_A0BD0E0A-9E4E-47AA-929A-5D73011B031A_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The accompanying financial statements have been prepared in
 accordance with accounting principles generally accepted in the
 United States of America (&amp;#x201C;US GAAP&amp;#x201D;) and pursuant to
 the accounting and disclosure rules and regulations of the SEC.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_CDF8B2B4-B37A-4FA5-8679-DC772A779DB4_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Cash and cash equivalents&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The Company considers all short-term investments with an original
 maturity of three&amp;#xA0;months or less when purchased to be cash
 equivalents. The Company did not have any cash equivalents as of
 December&amp;#xA0;31, 2019.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_A713BD55-C9F0-46AB-9CA6-6C3CF402F283_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Concentration of credit risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 Financial instruments that potentially subject the Company to
 concentrations of credit risk consist of cash accounts in a
 financial institution, which, at times may exceed the Federal
 Depository Insurance Coverage of $250,000. The Company has not
 experienced losses on these accounts and management believes the
 Company is not exposed to significant risks on such accounts.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:ProceedsFromRelatedPartyDebt contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_D796676A-6007-463B-8BDC-63722BB80AD9_1_5" unitRef="iso4217_USD">17631</us-gaap:ProceedsFromRelatedPartyDebt>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_332FB738-F0D1-4F85-A2C0-6C4368FBDF00_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Fair value of financial instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The fair value of the Company&amp;#x2019;s assets and liabilities, which
 qualify as financial instruments under ASC Topic 820, &amp;#x201C;Fair
 Value Measurements and Disclosures,&amp;#x201D; approximates the
 carrying amounts represented in the accompanying balance sheets,
 primarily due to their short-term nature.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_9A9B9C06-1215-40CF-B610-5CC980AEA180_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 &lt;b&gt;Note 1 &amp;#x2014; Organization and Plan of Business
 Operations&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 Social Capital Hedosophia Holdings Corp. III (the
 &amp;#x201C;Company&amp;#x201D;) is a newly incorporated blank check company
 incorporated as a Cayman Islands exempted company on
 October&amp;#xA0;18, 2019. The Company was formed for the purpose of
 effecting a merger, share exchange, asset acquisition, share
 purchase, reorganization or similar business combination with one
 or more businesses (a &amp;#x201C;Business Combination&amp;#x201D;).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 Although the Company is not limited to a particular industry or
 sector for purposes of consummating a Business Combination, the
 Company intends to focus on businesses in the technology industries
 primarily located in the United States. The Company is an early
 stage and emerging growth company and, as such, the Company is
 subject to all of the risks associated with early stage and
 emerging growth companies.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 As of December&amp;#xA0;31, 2019, the Company had not commenced any
 operations. All activity for the period from October&amp;#xA0;18, 2019
 (inception) through December&amp;#xA0;31, 2019 relates to the
 Company&amp;#x2019;s formation and the proposed initial public offering
 (&amp;#x201C;Proposed Public Offering&amp;#x201D;), which is described below.
 The Company will not generate any operating revenues until after
 the completion of a Business Combination, at the earliest. The
 Company will generate &lt;font style="WHITE-SPACE: nowrap"&gt;non-operating&lt;/font&gt; income in the form of
 interest income from the proceeds derived from the Proposed Public
 Offering.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 The Company&amp;#x2019;s ability to commence operations is contingent
 upon obtaining adequate financial resources through a Proposed
 Public Offering of 72,000,000&amp;#xA0;units (the &amp;#x201C;Units&amp;#x201D;
 and, with respect to the Class&amp;#xA0;A ordinary shares included in
 the Units being offered, the &amp;#x201C;Public Shares&amp;#x201D;) at $10.00
 per unit (or 82.800,000&amp;#xA0;Units if the underwriters&amp;#x2019;
 over-allotment option is exercised in full), which is discussed in
 Note 3 and the sale of 10,933,333 warrants (the &amp;#x201C;Private
 Placement Warrants&amp;#x201D;) at a price of $1.50 per Private
 Placement Warrant in a private placement to the Company&amp;#x2019;s
 sponsor, SCH Sponsor III LLC (f/k/a SCH Sponsor Corp. III), a
 Cayman Islands limited liability company (the
 &amp;#x201C;Sponsor&amp;#x201D;), that will close simultaneously with the
 Proposed Public Offering.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 The Company&amp;#x2019;s management has broad discretion with respect to
 the specific application of the net proceeds of the Proposed Public
 Offering and the sale of the Private Placement Warrants, although
 substantially all of the net proceeds are intended to be applied
 generally toward consummating a Business Combination. The New York
 Stock Exchange rules require that the Business Combination must be
 with one or more operating businesses or assets with a fair market
 value equal to at least 80% of the net assets held in the Trust
 Account (as defined below) (net of amounts disbursed to management
 for working capital purposes, if permitted, and excluding the
 amount of any deferred underwriting discount). The Company will
 only complete a Business Combination if the post-Business
 Combination company owns or acquires 50% or more of the issued and
 outstanding voting securities of the target or otherwise acquires a
 controlling interest in the target business sufficient for it not
 to be required to register as an investment company under the
 Investment Company Act of 1940, as amended (the &amp;#x201C;Investment
 Company Act&amp;#x201D;). There is no assurance that the Company will be
 able to successfully effect a Business Combination. Upon the
 closing of the Proposed Public Offering, management has agreed that
 $10.00 per Unit sold in the Proposed Public Offering, including
 proceeds of the sale of the Private Placement Warrants, will be
 held in a trust account (&amp;#x201C;Trust Account&amp;#x201D;) and invested
 in U.S. government securities, within the meaning set forth in
 Section&amp;#xA0;2(a)(16) of the Investment Company Act, with a
 maturity of 185&amp;#xA0;days or less, or in any open-ended investment
 company that holds itself out as a money market fund meeting the
 conditions of &lt;font style="WHITE-SPACE: nowrap"&gt;Rule&amp;#xA0;2a-7&lt;/font&gt; of the Investment
 Company Act, as determined by the Company, until the earlier of:
 (i)&amp;#xA0;the completion of a Business Combination and (ii)&amp;#xA0;the
 distribution of the funds in the Trust Account to the
 Company&amp;#x2019;s shareholders, as described below.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 The Company will provide the holders of the public shares (the
 &amp;#x201C;Public Shareholders&amp;#x201D;) with the opportunity to redeem
 all or a portion of their public shares upon the completion of the
 Business Combination, either (i)&amp;#xA0;in connection with a
 shareholder meeting called to approve the Business Combination or
 (ii)&amp;#xA0;by means of a tender offer. The decision as to whether
 the Company will seek shareholder approval of a Business
 Combination or conduct a tender offer will be made by the Company,
 solely in its discretion. The Public Shareholders will be entitled
 to redeem their shares for a pro&amp;#xA0;rata portion of the amount
 held in the Trust Account (initially $10.00 per share) as of two
 business days prior to the completion of a Business Combination,
 including any pro&amp;#xA0;rata interest earned on the funds held in
 the Trust Account and not previously released to the Company to pay
 its tax obligations. The &lt;font style="WHITE-SPACE: nowrap"&gt;per-share&lt;/font&gt; amount to be distributed to
 the Public Shareholders who redeem their shares will not be reduced
 by the deferred underwriting commissions the Company will pay to
 the underwriters (as discussed in Note 7). There will be no
 redemption rights upon the completion of a Business Combination
 with respect to the Company&amp;#x2019;s warrants.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 The Class&amp;#xA0;A ordinary shares will be recorded at redemption
 value and classified as temporary equity upon the completion of the
 Proposed Public Offering, in accordance with Accounting Standards
 Codification (&amp;#x201C;ASC&amp;#x201D;) Topic 480 &amp;#x201C;Distinguishing
 Liabilities from Equity.&amp;#x201D; The Company will proceed with a
 Business Combination only if the Company has net tangible assets,
 after payment of the deferred underwriting commission, of at least
 $5,000,001 upon such completion of a Business Combination and, if
 the Company seeks shareholder approval, it receives an ordinary
 resolution under Cayman Islands law approving a Business
 Combination, which requires the affirmative vote of a majority of
 the shareholders who attend and vote and a general meeting of the
 Company. If a shareholder vote is not required and the Company does
 not decide to hold a shareholder vote for business or other legal
 reasons, the Company will, pursuant to its Amended and Restated
 Memorandum and Articles of Association, conduct the redemptions
 pursuant to the tender offer rules of the Securities and Exchange
 Commission (&amp;#x201C;SEC&amp;#x201D;), and file tender offer documents
 containing substantially the same information as would be included
 in a proxy statement with the SEC prior to completing a Business
 Combination. If the Company seeks shareholder approval in
 connection with a Business Combination, the Company&amp;#x2019;s Sponsor
 has agreed to vote its Founder Shares (as defined in Note 5) and
 any Public Shares purchased during or after the Proposed Public
 Offering in favor of approving a Business Combination and to waive
 its redemption rights with respect to any such shares in connection
 with a shareholder vote to approve a Business Combination or seek
 to sell any shares to the Company in a tender offer in connection
 with a Business Combination. Additionally, subject to the
 immediately succeeding paragraph, each public shareholder may elect
 to redeem their Public Shares, without voting, and if they do vote,
 irrespective of whether they vote for or against a proposed
 Business Combination.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 Notwithstanding the foregoing, if the Company seeks shareholder
 approval of the Business Combination and the Company does not
 conduct redemptions pursuant to the tender offer rules, a Public
 Shareholder, together with any affiliate of such shareholder or any
 other person with whom such shareholder is acting in concert or as
 a &amp;#x201C;group&amp;#x201D; (as defined under Section&amp;#xA0;13 of the
 Securities Exchange Act of 1934, as amended (the &amp;#x201C;Exchange
 Act&amp;#x201D;)), will be restricted from redeeming its shares with
 respect to 15% or more of the Public Shares without the
 Company&amp;#x2019;s prior written consent.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 The Sponsor has agreed (a)&amp;#xA0;to waive its redemption rights with
 respect to any Founder Shares and Public Shares held by it in
 connection with the completion of a Business Combination (and not
 seek to sell its shares to the Company in any tender offer the
 Company undertakes in connection with its initial business
 combination) and (b)&amp;#xA0;not to propose an amendment to the
 Amended and Restated Memorandum of Articles of Association
 (i)&amp;#xA0;to modify the substance or timing of the Company&amp;#x2019;s
 obligation to redeem 100% of the Public Shares if the Company does
 not complete a Business Combination within Combination Period or
 (ii)&amp;#xA0;with respect to any other provision relating to
 shareholders&amp;#x2019; rights or &lt;font style="WHITE-SPACE: nowrap"&gt;pre-initial&lt;/font&gt; business combination
 activity, unless the Company provides the public shareholders with
 the opportunity to redeem their Public Shares in conjunction with
 any such amendment.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"&gt;
 The Company will have until 24&amp;#xA0;months from the closing of the
 Proposed Public Offering to consummate a Business Combination.
 However, if the Company has not completed a Business Combination
 within 24&amp;#xA0;months of the closing of the Proposed Public
 Offering (the &amp;#x201C;Combination Period&amp;#x201D;), the Company will
 (i)&amp;#xA0;cease all operations except for the purpose of winding up,
 (ii)&amp;#xA0;as promptly as reasonably possible but not more than ten
 business days thereafter, redeem the public shares, at a
 &lt;font style="WHITE-SPACE: nowrap"&gt;per-share&lt;/font&gt; price, payable
 in cash, equal to the aggregate amount then on deposit in the Trust
 Account, including interest (which interest shall be net of taxes
 payable, and less up to $100,000 of interest to pay dissolution
 expenses) divided by the number of then outstanding public shares,
 which redemption will completely extinguish the rights of the
 Public Shareholders as shareholders (including the right to receive
 further liquidation distributions, if any), subject to applicable
 law, and (iii)&amp;#xA0;as promptly as reasonably possible following
 such redemption, subject to the approval of the Company&amp;#x2019;s
 remaining Public Shareholders and its Board of Directors, liquidate
 and dissolve, subject in each case to the Company&amp;#x2019;s
 obligations under Cayman Islands law to provide for claims of
 creditors and the requirements of other applicable law. In the
 event of a liquidation, the Public Shareholders will be entitled to
 receive a full pro&amp;#xA0;rata interest in the Trust Account
 (initially anticipated to be approximately $10.00 per share, plus
 any pro&amp;#xA0;rata interest earned on the Trust Fund not previously
 released to the Company and less up to $100,000 of interest to pay
 dissolution expenses). There will be no redemption rights or
 liquidating distributions with respect to the Founder Shares or the
 Private Placement Warrants, which will expire worthless if the
 Company fails to complete a Business Combination within the
 Combination Period.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 In order to protect the amounts held in the Trust Account, the
 Sponsor has agreed that it will be liable to the Company, if and to
 the extent any claims by a third party (other than the
 Company&amp;#x2019;s independent auditors) for services rendered or
 products sold to the Company, or a prospective target business with
 which the Company has discussed entering into a transaction
 agreement, reduce the amount of funds in the Trust Account to below
 (1) $10.00 per Public Share or (2)&amp;#xA0;such lesser amount per
 Public Share held in the Trust Account as of the date of the
 liquidation of the Trust Account due to reductions in the value of
 trust assets, in each case net of the interest which may be
 withdrawn to pay taxes, except as to any claims by a third party
 who executed a waiver of any and all rights to seek access to the
 Trust Account and except as to any claims under the Company&amp;#x2019;s
 indemnity of the underwriters of the Proposed Public Offering
 against certain liabilities, including liabilities under the
 Securities Act of 1933, as amended (the &amp;#x201C;Securities
 Act&amp;#x201D;). In the event that an executed waiver is deemed to be
 unenforceable against a third party, the Sponsor will not be
 responsible to the extent of any liability for such third-party
 claims. The Company will seek to reduce the possibility that the
 Sponsor will have to indemnify the Trust Account due to claims of
 creditors by endeavoring to have all vendors, service providers
 (other than the Company&amp;#x2019;s independent auditors), prospective
 target businesses or other entities with which the Company does
 business, execute agreements with the Company waiving any right,
 title, interest or claim of any kind in or to monies held in the
 Trust Account.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Going Concern Consideration&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 At December&amp;#xA0;31, 2019, the Company had $0 in cash and a working
 capital deficit of $117,977. The Company has incurred and expects
 to continue to incur significant costs in pursuit of its financing
 and acquisition plans. These conditions raise substantial doubt
 about the Company&amp;#x2019;s ability to continue as a going concern
 within one year after the date that the financial statements are
 issued. Management plans to address this uncertainty through a
 Proposed Public Offering as discussed in Note 3. There is no
 assurance that the Company&amp;#x2019;s plans to raise capital or to
 consummate a Business Combination will be successful or successful
 within the Combination Period. The financial statements do not
 include any adjustments that might result from the outcome of this
 uncertainty.&lt;/p&gt;


 &lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_20ED81C1-9718-48E5-AC62-70D5EC4FE2D9_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 5 &amp;#x2014; Related Party Transactions&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;&lt;i&gt;Founder Shares&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 In October&amp;#xA0;2019, the Company issued one ordinary share to the
 Sponsor for no consideration.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 The Sponsor has agreed, subject to limited exceptions, not to
 transfer, assign or sell any of its Class&amp;#xA0;B ordinary shares or
 Class&amp;#xA0;A ordinary shares received upon conversion thereof
 (together, &amp;#x201C;Founder Shares&amp;#x201D;) until the earlier of:
 (A)&amp;#xA0;one year after the completion of a Business Combination
 and (B)&amp;#xA0;subsequent to a Business Combination, (x)&amp;#xA0;if the
 last reported sale price of the Class&amp;#xA0;A ordinary shares equals
 or exceeds $12.00 per share (as adjusted for share splits, share
 dividends, rights issuances, subdivisions, reorganizations,
 recapitalizations and the like) for any 20 trading days within any
 &lt;font style="WHITE-SPACE: nowrap"&gt;30-trading&lt;/font&gt; day period
 commencing at least 150&amp;#xA0;days after a Business Combination, or
 (y)&amp;#xA0;the date on which the Company completes a liquidation,
 merger, amalgamation, share exchange, reorganization or other
 similar transaction that results in all of the Company&amp;#x2019;s
 shareholders having the right to exchange their Class&amp;#xA0;A
 ordinary shares for cash, securities or other property.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Advances &amp;#x2014; Related Party&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The Sponsor advanced the Company an aggregate of $17,631 to cover
 expenses related to the Initial Public Offering. The advances are
 &lt;font style="WHITE-SPACE: nowrap"&gt;non-interest&lt;/font&gt; bearing and
 due on demand. At December&amp;#xA0;31, 2019, advances of $17,631 were
 outstanding.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Administrative Services Agreement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The Company will enter into an agreement pursuant to which it will
 pay an affiliate of the Sponsor up to $10,000 per month for office
 space, administrative and support services. Upon completion of a
 Business Combination or its liquidation, the Company will cease
 paying these monthly fees.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 18pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;&lt;i&gt;Related Party Loans&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 In order to finance transaction costs in connection with a Business
 Combination, the Sponsor or an affiliate of the Sponsor, or certain
 of the Company&amp;#x2019;s officers and directors may, but are not
 obligated to, loan the Company funds as may be required
 (&amp;#x201C;Working Capital Loans&amp;#x201D;). Such Working Capital Loans
 would be evidenced by promissory notes. The notes may be repaid
 upon completion of a Business Combination, without interest, or, at
 the lender&amp;#x2019;s discretion, up to $1,500,000 of notes may be
 converted upon completion of a Business Combination into warrants
 at a price of $1.50 per warrant. Such warrants would be identical
 to the Private Placement Warrants. In the event that a Business
 Combination does not close, the Company may use a portion of
 proceeds held outside the Trust Account to repay the Working
 Capital Loans but no proceeds held in the Trust Account would be
 used to repay the Working Capital Loans.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <ipoc:DeferredUnderwritingFees contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="2" id="id_10882567_ACEF1C61-E8FF-42F6-AC2B-510E2EE59509_1_1" unitRef="iso4217_USD">0.35</ipoc:DeferredUnderwritingFees>
  <ipoc:LoansConvertibleInToWarrants contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_757FC189-0E10-4E7E-9CA7-6FA05EC4E7B6_1_0" unitRef="iso4217_USD">1500000</ipoc:LoansConvertibleInToWarrants>
  <ipoc:UnderwritingDiscount contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_ACEF1C61-E8FF-42F6-AC2B-510E2EE59509_1_0" unitRef="iso4217_USD">14400000</ipoc:UnderwritingDiscount>
  <ipoc:PublicOfferingDisclosureTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_424ADBE8-CCDD-4ADF-B420-987B1D4048A7_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 3 &amp;#x2014; Proposed Public Offering&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 Pursuant to the Proposed Public Offering, the Company will offer
 for sale up to 72,000,000&amp;#xA0;Units (or 82,800,000&amp;#xA0;Units if
 the underwriters&amp;#x2019; over-allotment option is exercised in full)
 at a purchase price of $10.00 per Unit. Each Unit will consist of
 one Class&amp;#xA0;A ordinary share and &lt;font style="WHITE-SPACE: nowrap"&gt;one-third&lt;/font&gt; of one redeemable warrant
 (&amp;#x201C;Public Warrant&amp;#x201D;). Each whole Public Warrant will
 entitle the holder to purchase one Class&amp;#xA0;A ordinary share at
 an exercise price of $11.50 per whole share (see Note 7).&lt;/p&gt;


 &lt;/div&gt;</ipoc:PublicOfferingDisclosureTextBlock>
  <ipoc:DeferredOfferingCostsPolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_7F9580DC-D729-44E2-8CFF-DBA260690561_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;&lt;i&gt;Deferred offering costs&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 Deferred offering costs consist of underwriting, legal, accounting
 and other expenses incurred through the balance sheet date that are
 directly related to the Proposed Public Offering and that will be
 charged to shareholder&amp;#x2019;s equity upon the completion of the
 Proposed Public Offering. Should the Proposed Public Offering prove
 to be unsuccessful, these deferred costs, as well as additional
 expenses incurred, will be charged to operations.&lt;/p&gt;
 &lt;/div&gt;</ipoc:DeferredOfferingCostsPolicyTextBlock>
  <ipoc:PrivatePlacementDisclosureTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_F2BAA7DB-67F0-4ED1-9B06-EBEE46C16BEB_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 4 &amp;#x2014; Private Placement&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The Sponsor has committed to purchase an aggregate of 10,933,333
 Private Placement Warrants at a price of $1.50 per Private
 Placement Warrant ($16,400,000 in the aggregate) from the Company
 in a private placement that will occur simultaneously with the
 closing of the Proposed Public Offering. The proceeds from the sale
 of the Private Placement Warrants will be added to the net proceeds
 from the Proposed Public Offering held in the Trust Account. Each
 Private Placement Warrant is exercisable for one Class&amp;#xA0;A Share
 at a price of $11.50 per share, subject to adjustment (see Note 7).
 If the Company does not complete a Business Combination within the
 Combination Period, the proceeds from the sale of the Private
 Placement Warrants held in the Trust Account will be used to fund
 the redemption of the Public Shares (subject to the requirements of
 applicable law) and the Private Placement Warrants will expire
 worthless.&lt;/p&gt;
 &lt;/div&gt;</ipoc:PrivatePlacementDisclosureTextBlock>
  <ipoc:FormationAndOperatingCosts contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_16D99B35-C075-4A78-8FCD-F0DF0E0CFB30_1_0" unitRef="iso4217_USD">17631</ipoc:FormationAndOperatingCosts>
  <ipoc:DeferredOfferingCostsIncludedInAccruedOfferingCosts contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_D796676A-6007-463B-8BDC-63722BB80AD9_1_12" unitRef="iso4217_USD">100346</ipoc:DeferredOfferingCostsIncludedInAccruedOfferingCosts>
  <ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_98E3FC4E-1788-45AC-9AF4-D1A3A6142EA4_5005_800003" unitRef="iso4217_USD">0</ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue>
  <ipoc:CompanyGrowthPolicyPolicyTextBlock contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_6B535D9E-CEA4-4775-9051-9FA4DA42B036_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Emerging growth company&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The Company is an &amp;#x201C;emerging growth company,&amp;#x201D; as defined
 in Section&amp;#xA0;2(a) of the Securities Act, as modified by the
 Jumpstart Our Business Startups Act of 2012 (the &amp;#x201C;JOBS
 Act&amp;#x201D;), and it may take advantage of certain exemptions from
 various reporting requirements that are applicable to other public
 companies that are not emerging growth companies including, but not
 limited to, not being required to comply with the auditor
 attestation requirements of Section&amp;#xA0;404 of the Sarbanes-Oxley
 Act, reduced disclosure obligations regarding executive
 compensation in its periodic reports and proxy statements, and
 exemptions from the requirements of holding a nonbinding advisory
 vote on executive compensation and shareholder approval of any
 golden parachute payments not previously approved.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 Further, Section&amp;#xA0;102(b)(1) of the JOBS Act exempts emerging
 growth companies from being required to comply with new or revised
 financial accounting standards until private companies (that is,
 those that have not had a Securities Act registration statement
 declared effective or do not have a class of securities registered
 under the Exchange Act) are required to comply with the new or
 revised financial accounting standards. The JOBS Act provides that
 a company can elect to opt out of the extended transition period
 and comply with the requirements that apply to &lt;font style="WHITE-SPACE: nowrap"&gt;non-emerging&lt;/font&gt; growth companies but any
 such election to opt out is irrevocable. The Company has elected
 not to opt out of such extended transition period which means that
 when a standard is issued or revised and it has different
 application dates for public or private companies, the Company, as
 an emerging growth company, can adopt the new or revised standard
 at the time private companies adopt the new or revised standard.
 This may make comparison of the Company&amp;#x2019;s financial
 statements with another public company which is neither an emerging
 growth company nor an emerging growth company which has opted out
 of using the extended transition period difficult or impossible
 because of the potential differences in accounting standards
 used.&lt;/p&gt;
 &lt;/div&gt;</ipoc:CompanyGrowthPolicyPolicyTextBlock>
  <ipoc:UnderwritingDiscountPercentage contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="2" id="id_10882567_46D98663-C86A-4CA4-B599-B9252C0E4EC3_1_0" unitRef="pure">0.10</ipoc:UnderwritingDiscountPercentage>
  <ipoc:WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_6B772E06-EDE1-474B-824F-DACE8A42F94D_1_0">P12M</ipoc:WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering>
  <ipoc:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_6B772E06-EDE1-474B-824F-DACE8A42F94D_1_1">P30D</ipoc:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
  <ipoc:ThresholdPeriodForFillingRegistrationStatementAfterBusinessCombination contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_95DBE25A-B449-4F52-B2E6-553F9AE4DC05_1_0">P15D</ipoc:ThresholdPeriodForFillingRegistrationStatementAfterBusinessCombination>
  <ipoc:ThresholdPeriodForFilingRegistrationStatementWithinNumberOfDaysOfBusinessCombination contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" id="id_10882567_95DBE25A-B449-4F52-B2E6-553F9AE4DC05_1_1">P60D</ipoc:ThresholdPeriodForFilingRegistrationStatementWithinNumberOfDaysOfBusinessCombination>
  <ipoc:ClassOfWarrantOrRightAggregateCommittedPurchasePrice contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0" decimals="0" id="id_10882567_F66011C2-DED6-4D27-A328-074D12F0AF64_1_0" unitRef="iso4217_USD">16400000</ipoc:ClassOfWarrantOrRightAggregateCommittedPurchasePrice>
  <ipoc:CommonStockVotingRightsPerShare contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2235940x2255133" decimals="INF" id="id_10882567_0C8C89C5-1BAA-4890-8B4D-77AB752AD1E2_1001_2" unitRef="Vote">1</ipoc:CommonStockVotingRightsPerShare>
  <ipoc:CommonStockVotingRightsPerShare contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2235940x2255134" decimals="INF" id="id_10882567_9B54A77D-C46B-4E0C-AF64-75B4FD4CD860_1001_2" unitRef="Vote">1</ipoc:CommonStockVotingRightsPerShare>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_98E3FC4E-1788-45AC-9AF4-D1A3A6142EA4_5001_500005" unitRef="iso4217_USD">0</us-gaap:NetIncomeLoss>
  <ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_98E3FC4E-1788-45AC-9AF4-D1A3A6142EA4_5001_500003" unitRef="iso4217_USD">0</ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue>
  <ipoc:StockIssuedDuringPeriodClassBsharesNewIssues contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_98E3FC4E-1788-45AC-9AF4-D1A3A6142EA4_5001_400004" unitRef="shares">1</ipoc:StockIssuedDuringPeriodClassBsharesNewIssues>
  <ipoc:ClassOfWarrantOrRightPerWarrant contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2238403x2380265" decimals="2" id="id_10882567_1D7DD739-E156-46FE-9507-156F4F2CD49E_1001_4" unitRef="iso4217_USD_per_shares">1.50</ipoc:ClassOfWarrantOrRightPerWarrant>
  <ipoc:ClassOfWarrantOrRightNumbersCommittedForPurchase contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2238403x2380265" decimals="0" id="id_10882567_1D7DD739-E156-46FE-9507-156F4F2CD49E_1001_3" unitRef="shares">10933333</ipoc:ClassOfWarrantOrRightNumbersCommittedForPurchase>
  <ipoc:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2238403x2464594" id="id_10882567_00EED9C2-119A-41FA-B82E-BFA64F97CACD_1001_1">P30D</ipoc:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
  <ipoc:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2238403x2464594" id="id_10882567_00EED9C2-119A-41FA-B82E-BFA64F97CACD_1001_2">P20D</ipoc:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
  <ipoc:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2238403x2464598" id="id_10882567_23A436F9-B84F-4DF4-B22B-5EA8311DF45F_1001_1">P30D</ipoc:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2243318x2386927_2251395x2251400" decimals="INF" id="id_10882567_C67E3B83-85C2-4C36-BD27-44273C6D1CCC_1001_0" unitRef="shares">10800000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <ipoc:AdditionalUnitsOptionsToPurchasePeriod contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2243318x2386927_2251395x2251400" id="id_10882567_C67E3B83-85C2-4C36-BD27-44273C6D1CCC_1001_1">P45D</ipoc:AdditionalUnitsOptionsToPurchasePeriod>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2244216x2236750" decimals="0" id="id_10882567_98E3FC4E-1788-45AC-9AF4-D1A3A6142EA4_5003_600005" unitRef="iso4217_USD">0</us-gaap:NetIncomeLoss>
  <ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2244216x2236750" decimals="0" id="id_10882567_98E3FC4E-1788-45AC-9AF4-D1A3A6142EA4_5003_600003" unitRef="iso4217_USD">0</ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2244216x2249289" decimals="0" id="id_10882567_98E3FC4E-1788-45AC-9AF4-D1A3A6142EA4_5004_700005" unitRef="iso4217_USD">-17631</us-gaap:NetIncomeLoss>
  <ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2244216x2249289" decimals="0" id="id_10882567_98E3FC4E-1788-45AC-9AF4-D1A3A6142EA4_5004_700003" unitRef="iso4217_USD">0</ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue>
  <ipoc:FounderSharesTransferAssignmentOrSaleCommencementPeriodAfterBusinessCombination contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2249317x2427612" id="id_10882567_80E008CD-C1A8-44D0-95F7-FD70574C058B_1001_0">P1Y</ipoc:FounderSharesTransferAssignmentOrSaleCommencementPeriodAfterBusinessCombination>
  <ipoc:UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2251395x2251396" id="id_10882567_76198381-3CF8-40B1-A599-5FCE601A72F2_1001_3">Each Unit will consist of one Class A ordinary share and one-third of one redeemable warrant ("Public Warrant").</ipoc:UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription>
  <ipoc:PublicOfferingPricePerShare contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2251395x2251396" decimals="2" id="id_10882567_1D7DD739-E156-46FE-9507-156F4F2CD49E_2001_1" unitRef="iso4217_USD_per_shares">10.00</ipoc:PublicOfferingPricePerShare>
  <ipoc:SaleOfStockNumberOfSharesToBeOfferedInInitialPublicOffer contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2251395x2251396" decimals="0" id="id_10882567_1D7DD739-E156-46FE-9507-156F4F2CD49E_2001_0" unitRef="shares">72000000</ipoc:SaleOfStockNumberOfSharesToBeOfferedInInitialPublicOffer>
  <ipoc:SaleOfStockNumberOfSharesToBeOfferedInInitialPublicOffer contextRef="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2251395x2251396_2360753x2370911" decimals="0" id="id_10882567_1D7DD739-E156-46FE-9507-156F4F2CD49E_3001_2" unitRef="shares">82800000</ipoc:SaleOfStockNumberOfSharesToBeOfferedInInitialPublicOffer>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_91_20200331_0" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_4007_1000007" unitRef="iso4217_USD">0</us-gaap:NetIncomeLoss>
  <ipoc:ClassBsharesCancelledDuringPeriodValue contextRef="eol_PE1111026-20S-4-0006_STD_91_20200331_0" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_4007_3" unitRef="iso4217_USD">0</ipoc:ClassBsharesCancelledDuringPeriodValue>
  <ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue contextRef="eol_PE1111026-20S-4-0006_STD_91_20200331_0" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_4007_1000005" unitRef="iso4217_USD">25000</ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue>
  <ipoc:ClassBsharesCancelledDuringPeriodValue contextRef="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2235940x2255133_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_4001_3" unitRef="iso4217_USD">0</ipoc:ClassBsharesCancelledDuringPeriodValue>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_4003_700007" unitRef="iso4217_USD">0</us-gaap:NetIncomeLoss>
  <ipoc:ClassBsharesCancelledDuringPeriodValue contextRef="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_4003_3" unitRef="iso4217_USD">0</ipoc:ClassBsharesCancelledDuringPeriodValue>
  <ipoc:ClassBsharesCancelledDuringPeriodShares contextRef="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_4003_600004" unitRef="shares">-1</ipoc:ClassBsharesCancelledDuringPeriodShares>
  <ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue contextRef="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_4003_700005" unitRef="iso4217_USD">2070</ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue>
  <ipoc:StockIssuedDuringPeriodClassBsharesNewIssues contextRef="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_4003_600006" unitRef="shares">20700000</ipoc:StockIssuedDuringPeriodClassBsharesNewIssues>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2244216x2236750" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_4005_800007" unitRef="iso4217_USD">0</us-gaap:NetIncomeLoss>
  <ipoc:ClassBsharesCancelledDuringPeriodValue contextRef="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2244216x2236750" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_4005_3" unitRef="iso4217_USD">0</ipoc:ClassBsharesCancelledDuringPeriodValue>
  <ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue contextRef="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2244216x2236750" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_4005_800005" unitRef="iso4217_USD">22930</ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2244216x2249289" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_4006_900007" unitRef="iso4217_USD">0</us-gaap:NetIncomeLoss>
  <ipoc:ClassBsharesCancelledDuringPeriodValue contextRef="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2244216x2249289" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_4006_3" unitRef="iso4217_USD">0</ipoc:ClassBsharesCancelledDuringPeriodValue>
  <ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue contextRef="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2244216x2249289" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_4006_900005" unitRef="iso4217_USD">0</ipoc:StockIssuedDuringPeriodValueClassBsharesNewIssue>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6007_1000017" unitRef="iso4217_USD">-56565</us-gaap:NetIncomeLoss>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6007_1000013" unitRef="iso4217_USD">16400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6007_1000010" unitRef="iso4217_USD">783843654</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <ipoc:OrdinarySharesSubjectToPossibleRedemptionValue contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6007_1000015" unitRef="iso4217_USD">795194456</ipoc:OrdinarySharesSubjectToPossibleRedemptionValue>
  <ipoc:ClassOfWarrantOrRightNumbersIssued contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6007_1000014" unitRef="shares">10933333</ipoc:ClassOfWarrantOrRightNumbersIssued>
  <ipoc:UnitsIssuedDuringPeriodSharesNewIssues contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6007_1000012" unitRef="shares">82800000</ipoc:UnitsIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2235940x2255133_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6001_400011" unitRef="shares">82800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2235940x2255133_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6001_500010" unitRef="iso4217_USD">8280</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <ipoc:OrdinarySharesSubjectToPossibleRedemptionShares contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2235940x2255133_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6001_400016" unitRef="shares">-79513276</ipoc:OrdinarySharesSubjectToPossibleRedemptionShares>
  <ipoc:OrdinarySharesSubjectToPossibleRedemptionValue contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2235940x2255133_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6001_500015" unitRef="iso4217_USD">7951</ipoc:OrdinarySharesSubjectToPossibleRedemptionValue>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6003_700017" unitRef="iso4217_USD">0</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6003_600011" unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6003_700013" unitRef="iso4217_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6003_700010" unitRef="iso4217_USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <ipoc:OrdinarySharesSubjectToPossibleRedemptionShares contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6003_600016" unitRef="shares">0</ipoc:OrdinarySharesSubjectToPossibleRedemptionShares>
  <ipoc:OrdinarySharesSubjectToPossibleRedemptionValue contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6003_700015" unitRef="iso4217_USD">0</ipoc:OrdinarySharesSubjectToPossibleRedemptionValue>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2244216x2236750" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6005_800017" unitRef="iso4217_USD">0</us-gaap:NetIncomeLoss>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2244216x2236750" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6005_800013" unitRef="iso4217_USD">16400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2244216x2236750" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6005_800010" unitRef="iso4217_USD">783835374</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <ipoc:OrdinarySharesSubjectToPossibleRedemptionValue contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2244216x2236750" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6005_800015" unitRef="iso4217_USD">795186505</ipoc:OrdinarySharesSubjectToPossibleRedemptionValue>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2244216x2249289" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6006_900017" unitRef="iso4217_USD">-56565</us-gaap:NetIncomeLoss>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2244216x2249289" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6006_900013" unitRef="iso4217_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2244216x2249289" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6006_900010" unitRef="iso4217_USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <ipoc:OrdinarySharesSubjectToPossibleRedemptionValue contextRef="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2244216x2249289" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_6006_900015" unitRef="iso4217_USD">0</ipoc:OrdinarySharesSubjectToPossibleRedemptionValue>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0" decimals="0" id="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_1_3" unitRef="iso4217_USD">32361</us-gaap:InvestmentIncomeInterest>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0" decimals="0" id="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_1_4" unitRef="iso4217_USD">-2293004</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0" decimals="2" id="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_1_6" unitRef="iso4217_USD_per_shares">-0.10</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0" decimals="0" id="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_1_1" unitRef="iso4217_USD">-2325365</us-gaap:OperatingIncomeLoss>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0" decimals="0" id="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_1_5" unitRef="shares">23986724</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:TemporaryEquityNetIncome contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0" decimals="0" id="id_10882567_944ACFA1-B2C4-4215-90F1-7349EBA04FBE_1_0" unitRef="iso4217_USD">-30986</us-gaap:TemporaryEquityNetIncome>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0" decimals="0" id="id_10882567_82983694-C9DE-4276-84E1-D77BF1BFE747_2_1" unitRef="iso4217_USD">30000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <ipoc:FormationAndOperatingCosts contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0" decimals="0" id="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_1_0" unitRef="iso4217_USD">2325365</ipoc:FormationAndOperatingCosts>
  <ipoc:AdjustedNetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0" decimals="0" id="id_10882567_32E9D1AE-D63E-4A63-97F9-D035A1E8590F_1_3" unitRef="iso4217_USD">-2323990</ipoc:AdjustedNetIncomeLoss>
  <ipoc:IncreaseDecreaseInValueOfOrdinarySharesSubjectToRedemption contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_9007_1000020" unitRef="iso4217_USD">2293005</ipoc:IncreaseDecreaseInValueOfOrdinarySharesSubjectToRedemption>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0_2235940x2255133_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_9001_500022" unitRef="iso4217_USD">0</us-gaap:NetIncomeLoss>
  <ipoc:IncreaseDecreaseInValueOfOrdinarySharesSubjectToRedemption contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0_2235940x2255133_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_9001_500020" unitRef="iso4217_USD">23</ipoc:IncreaseDecreaseInValueOfOrdinarySharesSubjectToRedemption>
  <ipoc:IncreaseDecreaseInValueOfOrdinarySharesSubjectToRedemptionShare contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0_2235940x2255133_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_9001_400021" unitRef="shares">232381</ipoc:IncreaseDecreaseInValueOfOrdinarySharesSubjectToRedemptionShare>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_9003_700022" unitRef="iso4217_USD">0</us-gaap:NetIncomeLoss>
  <ipoc:IncreaseDecreaseInValueOfOrdinarySharesSubjectToRedemption contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_9003_700020" unitRef="iso4217_USD">0</ipoc:IncreaseDecreaseInValueOfOrdinarySharesSubjectToRedemption>
  <ipoc:IncreaseDecreaseInValueOfOrdinarySharesSubjectToRedemptionShare contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0_2235940x2255134_2244216x2235106" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_9003_600021" unitRef="shares">0</ipoc:IncreaseDecreaseInValueOfOrdinarySharesSubjectToRedemptionShare>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0_2244216x2236750" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_9005_800022" unitRef="iso4217_USD">0</us-gaap:NetIncomeLoss>
  <ipoc:IncreaseDecreaseInValueOfOrdinarySharesSubjectToRedemption contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0_2244216x2236750" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_9005_800020" unitRef="iso4217_USD">2292982</ipoc:IncreaseDecreaseInValueOfOrdinarySharesSubjectToRedemption>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0_2244216x2249289" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_9006_900022" unitRef="iso4217_USD">-2293004</us-gaap:NetIncomeLoss>
  <ipoc:IncreaseDecreaseInValueOfOrdinarySharesSubjectToRedemption contextRef="eol_PE1111026-20S-4-0006_STD_92_20200930_0_2244216x2249289" decimals="0" id="id_10882567_F42823CF-C973-44A0-9999-45A49A408481_9006_900020" unitRef="iso4217_USD">0</ipoc:IncreaseDecreaseInValueOfOrdinarySharesSubjectToRedemption>
  <context id="eol_PE1111026-20S-4-0006_STD_92_20200930_0_2244216x2249289">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-07-01</startDate>
      <endDate>2020-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_92_20200930_0_2244216x2236750">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-07-01</startDate>
      <endDate>2020-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_92_20200930_0_2235940x2255134_2244216x2235106">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-07-01</startDate>
      <endDate>2020-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_92_20200930_0_2235940x2255133_2244216x2235106">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-07-01</startDate>
      <endDate>2020-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_92_20200930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
    </entity>
    <period>
      <startDate>2020-07-01</startDate>
      <endDate>2020-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2244216x2249289">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-04-01</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2244216x2236750">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-04-01</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2235940x2255134_2244216x2235106">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-04-01</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_91_20200630_0_2235940x2255133_2244216x2235106">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-04-01</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_91_20200630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
    </entity>
    <period>
      <startDate>2020-04-01</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2244216x2249289">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-01-01</startDate>
      <endDate>2020-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2244216x2236750">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-01-01</startDate>
      <endDate>2020-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2235940x2255134_2244216x2235106">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-01-01</startDate>
      <endDate>2020-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_91_20200331_0_2235940x2255133_2244216x2235106">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-01-01</startDate>
      <endDate>2020-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_91_20200331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
    </entity>
    <period>
      <startDate>2020-01-01</startDate>
      <endDate>2020-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2251395x2251396_2360753x2370911">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ipoc:SaleOfStockOfferingAxis">ipoc:UnderwritersOverallotmentOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-10-18</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2251395x2251396">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-10-18</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2249317x2427612">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">ipoc:ScenarioOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-10-18</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2244216x2249289">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-10-18</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2244216x2236750">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-10-18</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2243318x2386927_2251395x2251400">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">ipoc:UnderwritingAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-10-18</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2238403x2464598">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ipoc:RedemptionOfWarrantPricePerShareEqualsOrExceeds10Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-10-18</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2238403x2464594">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ipoc:RedemptionOfWarrantPricePerShareEqualsOrExceeds18Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-10-18</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2238403x2380265">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ipoc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-10-18</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2235940x2255134_2244216x2235106">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-10-18</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2235940x2255134">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-10-18</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_75_20191231_0_2235940x2255133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-10-18</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_75_20191231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
    </entity>
    <period>
      <startDate>2019-10-18</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_31_20191031_0_2251395x2251400">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-10-01</startDate>
      <endDate>2019-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_31_20191031_0_2244216x2383821">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipoc:SponsorMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-10-01</startDate>
      <endDate>2019-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_31_20191031_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
    </entity>
    <period>
      <startDate>2019-10-01</startDate>
      <endDate>2019-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2252772x2380357">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ipoc:RelatedPartyLoansMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-01-01</startDate>
      <endDate>2020-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2246129x2246008_2252772x2380357">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ipoc:RelatedPartyLoansMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-01-01</startDate>
      <endDate>2020-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2244216x2383821_2251395x2251400">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipoc:SponsorMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-01-01</startDate>
      <endDate>2020-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2238403x2464598">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ipoc:RedemptionOfWarrantPricePerShareEqualsOrExceeds10Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-01-01</startDate>
      <endDate>2020-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2238403x2464594">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ipoc:RedemptionOfWarrantPricePerShareEqualsOrExceeds18Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-01-01</startDate>
      <endDate>2020-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2238403x2380265">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ipoc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-01-01</startDate>
      <endDate>2020-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2235940x2255134">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-01-01</startDate>
      <endDate>2020-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_274_20200930_0_2235940x2255133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-01-01</startDate>
      <endDate>2020-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_274_20200930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
    </entity>
    <period>
      <startDate>2020-01-01</startDate>
      <endDate>2020-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_1_20200121_0_2237543x2237544_2244216x2383821">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipoc:SponsorMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-01-21</startDate>
      <endDate>2020-01-21</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_1_20201019_0_2237543x2237544_2238328x2381242">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ipoc:PromissoryNoteMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-10-19</startDate>
      <endDate>2020-10-19</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_1_20201005_0_2235940x2255134_2237543x2237544_2252081x2366122">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ipoc:MergerAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-10-05</startDate>
      <endDate>2020-10-05</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_1_20201005_0_2235940x2255134_2237543x2237544_2246129x2246008_2252081x2366122">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ipoc:MergerAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-10-05</startDate>
      <endDate>2020-10-05</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_1_20201005_0_2235940x2255133_2237543x2237544">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-10-05</startDate>
      <endDate>2020-10-05</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_1_20200424_0_2251395x2251400">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-04-24</startDate>
      <endDate>2020-04-24</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_1_20200424_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
    </entity>
    <period>
      <startDate>2020-04-24</startDate>
      <endDate>2020-04-24</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_1_20200421_0_2244216x2383821">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipoc:SponsorMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-04-21</startDate>
      <endDate>2020-04-21</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_1_20200421_0_2237543x2237544_2244216x2383821_2251395x2251400">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipoc:SponsorMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-04-21</startDate>
      <endDate>2020-04-21</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_1_20200421_0_2237543x2237544_2244216x2383821">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipoc:SponsorMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2020-04-21</startDate>
      <endDate>2020-04-21</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_1_20200421_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
    </entity>
    <period>
      <startDate>2020-04-21</startDate>
      <endDate>2020-04-21</endDate>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200121_0_2237543x2237544_2244216x2383821">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipoc:SponsorMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-01-21</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200121_0_2237543x2237544_2238328x2249158_2244216x2383821">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipoc:SponsorMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-01-21</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2251395x2251396">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2249317x2412147">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">ipoc:ScenarioTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2244216x2383821">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipoc:SponsorMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2244216x2249289">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2244216x2236750">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2238403x2464598">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ipoc:RedemptionOfWarrantPricePerShareEqualsOrExceeds10Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2238403x2464594">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ipoc:RedemptionOfWarrantPricePerShareEqualsOrExceeds18Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255134_2244216x2235106">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255134">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191231_0_2235940x2255133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
    </entity>
    <period>
      <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20201019_0_2237543x2237544_2238328x2381242">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ipoc:PromissoryNoteMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-10-19</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20201005_0_2235940x2255134_2237543x2237544_2252081x2366122">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ipoc:MergerAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-10-05</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20201005_0_2235940x2255133_2237543x2237544">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-10-05</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2250195x2235117">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-09-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2244216x2383821">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipoc:SponsorMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-09-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2244216x2249289">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-09-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2244216x2236750">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-09-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2238403x2464598">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ipoc:RedemptionOfWarrantPricePerShareEqualsOrExceeds10Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-09-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2238403x2464594">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ipoc:RedemptionOfWarrantPricePerShareEqualsOrExceeds18Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-09-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255134_2244216x2235106">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-09-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255134">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-09-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255133_2244216x2383821">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipoc:SponsorMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-09-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255133_2244216x2235106">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-09-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200930_0_2235940x2255133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-09-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
    </entity>
    <period>
      <instant>2020-09-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200630_0_2244216x2249289">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200630_0_2244216x2236750">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200630_0_2235940x2255134_2244216x2235106">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200630_0_2235940x2255133_2244216x2235106">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200331_0_2244216x2249289">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-03-31</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200331_0_2244216x2236750">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-03-31</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200331_0_2235940x2255134_2244216x2235106">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-03-31</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
    </entity>
    <period>
      <instant>2020-03-31</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191017_0_2244216x2249289">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-10-17</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191017_0_2244216x2236750">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-10-17</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191017_0_2235940x2255134_2244216x2235106">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-10-17</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191017_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
    </entity>
    <period>
      <instant>2019-10-17</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200424_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
    </entity>
    <period>
      <instant>2020-04-24</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20200229_0_2238328x2249158_2244216x2383821">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipoc:SponsorMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2020-02-29</instant>
    </period>
  </context>
  <context id="eol_PE1111026-20S-4-0006_STD_0_20191031_0_2244216x2383821">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001801170</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipoc:SponsorMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-10-31</instant>
    </period>
  </context>
  <unit id="iso4217_USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="iso4217_USD_per_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="shares">
    <measure>shares</measure>
  </unit>
  <unit id="pure">
    <measure>pure</measure>
  </unit>
  <unit id="Vote">
    <measure>ipoc:Vote</measure>
  </unit>
  <xbrll:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <xbrll:loc xlink:href="#id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_1_5" xlink:label="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_1_5" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_1_6" xlink:label="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_1_6" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_2_5" xlink:label="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_2_5" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_2_6" xlink:label="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_2_6" xlink:type="locator"/>
    <xbrll:footnote xlink:label="footnote_834234732" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Net loss per ordinary share - basic and diluted excludes income attributable to ordinary shares subject to possible redemption of $30,986 and $92,501 for the three and nine months ended September 30, 2020, respectively (see Note 2).</xbrll:footnote>
    <xbrll:footnote xlink:label="footnote_834234737" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Excludes an aggregate of 79,280,895 shares subject to possible redemption.</xbrll:footnote>
    <xbrll:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_1_5" xlink:to="footnote_834234737" xlink:type="arc"/>
    <xbrll:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_1_6" xlink:to="footnote_834234732" xlink:type="arc"/>
    <xbrll:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_2_5" xlink:to="footnote_834234737" xlink:type="arc"/>
    <xbrll:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="id_10882567_99DCB0B5-D0C4-4A6A-91F8-FA9B7E09C715_2_6" xlink:to="footnote_834234732" xlink:type="arc"/>
  </xbrll:footnoteLink>

</xbrl>
